POPULARITY
470 episodes with EPS
51 episodes with EPS
53 episodes with EPS
41 episodes with EPS
56 episodes with EPS
30 episodes with EPS
34 episodes with EPS
26 episodes with EPS
20 episodes with EPS
34 episodes with EPS
28 episodes with EPS
23 episodes with EPS
13 episodes with EPS
20 episodes with EPS
18 episodes with EPS
26 episodes with EPS
24 episodes with EPS
16 episodes with EPS
17 episodes with EPS
19 episodes with EPS
14 episodes with EPS
302 episodes with EPS
14 episodes with EPS
13 episodes with EPS
12 episodes with EPS
15 episodes with EPS
13 episodes with EPS
23 episodes with EPS
8 episodes with EPS
14 episodes with EPS
204 episodes with EPS
9 episodes with EPS
10 episodes with EPS
11 episodes with EPS
7 episodes with EPS
13 episodes with EPS
17 episodes with EPS
17 episodes with EPS
9 episodes with EPS
9 episodes with EPS
15 episodes with EPS
8 episodes with EPS
6 episodes with EPS
5 episodes with EPS
7 episodes with EPS
5 episodes with EPS
7 episodes with EPS
5 episodes with EPS
6 episodes with EPS
7 episodes with EPS
5 episodes with EPS
5 episodes with EPS
7 episodes with EPS
5 episodes with EPS
6 episodes with EPS
11 episodes with EPS
3 episodes with EPS
5 episodes with EPS
8 episodes with EPS
5 episodes with EPS
7 episodes with EPS
6 episodes with EPS
3 episodes with EPS
5 episodes with EPS
5 episodes with EPS
5 episodes with EPS
5 episodes with EPS
4 episodes with EPS
3 episodes with EPS
4 episodes with EPS
3 episodes with EPS
5 episodes with EPS
4 episodes with EPS
5 episodes with EPS
4 episodes with EPS
5 episodes with EPS
5 episodes with EPS
8 episodes with EPS
8 episodes with EPS
6 episodes with EPS
6 episodes with EPS
6 episodes with EPS
3 episodes with EPS
4 episodes with EPS
3 episodes with EPS
4 episodes with EPS
3 episodes with EPS
6 episodes with EPS
4 episodes with EPS
2 episodes with EPS
6 episodes with EPS
4 episodes with EPS
4 episodes with EPS
4 episodes with EPS
2 episodes with EPS
4 episodes with EPS
3 episodes with EPS
7 episodes with EPS
4 episodes with EPS
4 episodes with EPS
5 episodes with EPS
3 episodes with EPS
5 episodes with EPS
3 episodes with EPS
3 episodes with EPS
3 episodes with EPS
5 episodes with EPS
5 episodes with EPS
5 episodes with EPS
5 episodes with EPS
4 episodes with EPS
3 episodes with EPS
2 episodes with EPS
3 episodes with EPS
6 episodes with EPS
4 episodes with EPS
2 episodes with EPS
65 episodes with EPS
64 episodes with EPS
3 episodes with EPS
3 episodes with EPS
3 episodes with EPS
4 episodes with EPS
4 episodes with EPS
6 episodes with EPS
6 episodes with EPS
6 episodes with EPS
6 episodes with EPS
6 episodes with EPS
6 episodes with EPS
6 episodes with EPS
3 episodes with EPS
3 episodes with EPS
60 episodes with EPS
3 episodes with EPS
3 episodes with EPS
58 episodes with EPS
3 episodes with EPS
3 episodes with EPS
3 episodes with EPS
2 episodes with EPS
5 episodes with EPS
3 episodes with EPS
2 episodes with EPS
3 episodes with EPS
4 episodes with EPS
4 episodes with EPS
4 episodes with EPS
2 episodes with EPS
2 episodes with EPS
52 episodes with EPS
2 episodes with EPS
3 episodes with EPS
3 episodes with EPS
5 episodes with EPS
3 episodes with EPS
3 episodes with EPS
3 episodes with EPS
3 episodes with EPS
3 episodes with EPS
3 episodes with EPS
49 episodes with EPS
In each episode of our What's trending in SEC comments series, our guests bring you the latest themes in comment letters from the SEC's Division of Corporation Finance for the most common topical areas of the financial statements.This week we focus on debt, warrants, and equity. Tom Barbieri, a Deputy Chief Accountant in PwC's National Office, and John Horan, Managing Director in PwC's National Office, joined Heather Horn to break down some of the questions raised in these comments, giving you a deeper understanding of the SEC staff's expectations, as well as context and insights into the GAAP requirements.Topics include:1:46 - What types of comments are companies getting? Tom and John discuss the main themes of comments. Common questions relate to SPAC warrants and earnouts, debt modifications, preferred stock, embedded derivatives, and EPS.4:51 - SPAC warrants and earnouts. Accounting for SPAC warrants and earnouts can be complicated. John and Heather discuss the types of questions the SEC is asking on this topic and some best practices for determining the appropriate accounting.17:34 - Debt modifications and extinguishments. Accounting for a troubled debt restructuring, debt modifications, or extinguishment can be complex. Tom and Heather discuss some tips for getting disclosures about these transactions right the first time.23:51 - Preferred stock. John and Heather talk about the SEC staff's interest in particular topical areas when asking about preferred stock. 31:05 - Embedded derivatives. Tom and Heather discuss accounting for embedded conversion features and other redemption provisions, and the importance of providing the right level of context for these in your disclosures.33:51 - Earnings per share. EPS has continued to be an ongoing area of focus for the SEC staff. John explains some of the areas that might give rise to a comment.40:03 - Key takeaways and reminders. We close with some future areas to pay attention to and helpful advice for issuers to address these issues heading into year end. Heather tries to stump Tom and John with some niche accounting questions.Want to learn more?Listen to our previous comment letter podcasts: Revenue: What's trending in SEC comments, Goodwill: What's trending in SEC comments, and Inventory and cost of sales: What's trending in SEC comments, Segment reporting: What's trending in SEC commentsFinancial statement presentation guide: Chapter 5: Stockholders' Equity, Chapter 12: Debt, Chapter 19: Derivatives and HedgingSee our overview of SEC Comment Letter Trends
Eps. 69: Today on Two Mics Up we travel to Houston Texas and hit the Community ARC! We are joined by Zuriel Gibson, Founder and CEO of Gibson Lupus ARC who has dedicated herself to providing innovative resources that serve the Lupus & Autoimmune diseases community that promotes a long life until the cure comes. Tune in and get educated about how Lupus impacts so many people in our community and what you can do to help and support Gibson Lupus ARC. Featuring: Zuriel Gibson Founder and CEO Gibson Lupus ARC --- Support this podcast: https://anchor.fm/twomicsup/support
Aaron Bertram and Rachel Charest join Your Creative Journey to talk about their work as the creators of Kids Imagine Nation (KIN), a musical trio whose mission is to help their neighbors by using their imaginations! Over the past few years, KIN released 4 albums and 2 EPs, has performed live at the Disneyland Resort, Legoland, Santa's Village, and 100's or schools and libraries, created a web series that follows their adventures, and launched a live stream network called KINTV where they interact with their viewers live through the week with music classes, interactive storytimes dance parties and much much more! www.kinmusic.netYour Creative Journey explores the challenges creators can face as they forge their own paths. Whether you want to act, write, dance, draw, make music or make a movie, the Your Creative Journey Podcast is here for you! Twice a month, Paul and Kevin discuss their experiences as working creatives and offer any insight to help you get one step closer to making your creative dream a reality.For shows on The Vaudacity Networkhttp://vaudacitynetwork.com/Follow Kevin onhttps://kevingregg.locals.com/https://t.me/kevingreggshow#creativedesign #artcreative #creativityatitsbest #createveryday #creativeworld #creativeprocess #creativeminds #creativemind #creativityfound #creativeartist
Yep, you read the title right. This episode we are talking about money. It's a conversation that most people run from, but I want to share what I have learned about money from my own life and from the most recent SASS experience. I believe this is an essential conversation to have because it's really not about money. It's about self-worth. Your relationship with money is a reflection of your relationship with yourself. We need to ask questions like: What do I feel like I deserve or don't deserve? How do I value myself? Money is a mindset. It's about believing in your dreams, and it's about knowing that you deserve what you desire. I know that you might be thinking something like, "well, that's good for you, but I have a limited income and a family to support." If this is you, I want you to take one thing from this episode; you have to choose to change that. You have to decide to not stay in that energy any longer. You can't wait for things on the outside to change for you to change your life. Make the decision and lift the limitations you have set for yourself right now. Whatever relationship you have with money, expect to get your mind blown with this episode. Expect to lean in to learn more about it and learn what your guides want you to know about it. Don't forget to check out the incredible offer we have for you at https://www.marilynalauria.com/sale. If you have been thinking about joining Membership for Your Soul, you don't want to miss this chance. In this episode you'll learn about: Walking with money as your guide Reframing the story you have about money Learning how we assign value to things 03:40 - a little background on my money story 08:01 - using money as a guide 10:42 - a lesson on valuing things 18:26 - when you think something is expensive & when you really want something 36:34 - a walk with money meditation Related episodes: Ep 56: The Story I Never Wanted To Tell https://www.marilynalauria.com/eps-056-the-story-i-never-wanted-to-tell/ Eps 58: Truth, Faith and Surrender with Louise Matson https://www.marilynalauria.com/eps-058-truth-faith-and-surrender-with-louise-matson/ Ep 53: Expansion Out of Fear https://www.marilynalauria.com/eps-053-expansion-out-of-fear/ ******************************* Don't forget new episodes come out every Thursday! Follow and rate the podcast on Apple Podcast. Help us spread the word by sharing this episode with a friend. ******************************* If you have any questions for me, email whocanitbenowpodcast@gmail.com Get your Guide at https://marilynalauria.com/guide _______________________________ Follow me on social: Facebook: https://www.facebook.com/marilynalauria1 Instagram: https://www.instagram.com/marilynalauria
In a new installment of breaking down music put out during the pandemic, Kev and Jack look at a selection of albums and EPs released between late September and mid/late November 2021 across a mix of genres. From pop stars to smaller upcoming artists you may not know about yet, and everyone in-between (including the new Adele and Silk Sonic albums, to name a couple).
MEET AMANI ROBERTS:In the basement of an old bank in Washington DC, a college kid watched Biz Markie spin and his life changed forever. Now Amani Roberts (DJ AmRo) is a successful DJ, music producer, podcaster, educator, and business professional. With Bachelors of Business Administration from Howard University, Amani initially focused on developing his business skills in hotel sales management. But by 2008, he was already moving in music circles, creating his own podcasts, and spinning in local bars and clubs in California. He developed his skills both as a DJ and a music producer at the renowned Scratch Academy in Los Angeles skills that ultimately launched his DJ career. As well as performing around the world, Amani has co-released three remix EPs and runs a successful music business that caters to corporate clients. He's also an adjunct professor at California State University (CSUF) where he teaches Entertainment Money Management, and the co-director of the Center for Entertainment & Hospitality Management. Amani hosts and produces The Amani Experience Podcast, and has been featured in Yahoo! Finance,MPI, and on the Evan Holliday Podcast. Amani currently lives in Redondo Beach, California. CONTACT:https://www.amaniexperience.com (https://www.amaniexperience.com) https://twitter.com/amaniexperience (https://twitter.com/amaniexperience) https://www.instagram.com/amaniexperience/ (https://www.instagram.com/amaniexperience/) https://www.facebook.com/amaniexperience/ (https://www.facebook.com/amaniexperience/) https://www.linkedin.com/in/amaniroberts/ (https://www.linkedin.com/in/amaniroberts/) SUPPORT THE SHOW BECAUSE I LOVE PUPPIES!1)https://meetfox.com/en/ (MEETFOX) Monetize your time with an easy-to-use online platform. Use promo code “yuri” for 2 MONTHS FREE! 2) https://taliadinapoli.com/a/rewards/r/m8q3ZlTx (Talia di Napoli – PIZZA) Click on the title for $6.00 off your order of AMAZING pizza shipped fresh from Napoli https://www.gettaxhub.com/?rfsn=4356929.38ee2a (3) TAXHUB) NEED ACCOUNTING HELP? – Sign up for A Less Taxing Way To Work With A CPA. Get a free intro call with a tax professional. 4) https://www.audible.com/ep/freetrial?source_code=PDTGBPD060314004R (Audible.com) This podcast is brought to you by Audible. I have used Audible for years, and I love audiobooks. Click on the link to get a 30-day free trial, complete with a credit for a free audiobook download 5) ARE YOU INTERESTED IN BITCOIN OR CRYPTOCURRENCY?BUY MY BOOK BECAUSE IT'S AMAZING!!! I'll EVEN SIGN IT FOR YOU : )https://amzn.to/3afTmOu (BE LEFT BEHIND: Discover Bitcoin and Cryptocurrency Before Your Grandma Beats You to It) http://www.advanceyourart.com/captivate-podcast/eduardo-placer/yuricataldo.com (yuricataldo.com) CREDITS: Our theme music is written and mixed by Chicago-based composer, engineer, and multi-instrumentalist Ryan Black of the Black's Backbone collaborative. And produced by REB Records. This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy
Eps. 68: As we head into the Thanksgiving Holiday Week, Two Mics Up is all about Giving Thanks and we are honored to have some of our past celebrity guests share some of their favorite Thanksgiving Memories and what else they are thankful for this Holiday season. We are pleased to have the following guests join us on today's episode - Actress/Dancer and owner of The S.P.A.C.E. in Toronto Ontario Canada Linette Doherty, Actor/Director Lawrence Adisa - new film coming soon! And Actress/Writer and Comedian Karen Bankhead who also joins us with her alter-ego Etta Mae Mumphries! Tune in for the fun and also check out the details as Lawrence Adisa get his spades game on with his partner and long time friend Mekhi Phifer beginning December 1, 2021 on Caffeine TV. Featuring: Actor/Director: Lawrence Adisa Actress/Writer/Comedian: Karen Bankhead Actress/Dancer Owner of The S.P.A.C.E. Toronto: Linette Doherty --- Support this podcast: https://anchor.fm/twomicsup/support
In today's episode I have the great pleasure to talk to UK based author of two books and more to follow soon, teacher, martial artist and specialist on Daoist witchcraft, alchemy and magic, Jason Read. Jason's path started like probably a lot of ours out there with visiting a local bookstore. Getting his hands on Dion Fortunes ‘Psychic Self Defence' was just the first step in embarking on a journey of long and serious studies of Western Esotericism where he became familiar with the Golden Dawn's system as well as with Aleister Crowley's writings and a lot more important cornerstones in Western Esoteric Tradition. However, after some time Jason felt that he had to go back to some of the more original sources of Western Esotericism such as the writings of Heinrich Cornelius Agrippa and after embracing a Neoplatonic path he finally found himself to be attracted by references to Chinese magic made in Kenneth Grant's works. Fascinated by the Chinese traditions Jason decided to live and work in Asia for some time and learned Mandarin fluently. Soon he felt the need to look into forbidden occult Chinese practices in depth but something seemed to be missing to him personally so he relocated to Malaysia where he not only met his future wife but also came across his teacher and entered a 12 years long apprenticeship in the Maoshan tradition, a specific branch of Daoist practice. Find those book to buy HERE In this episode of the show we talk about all those common things that Daoism and Western magic share, point out one often enough overlooked key to magical systems in general and discuss the Western idea of Daoism as an invention. Jason sheds some light on the various branches of Daoism and explains the differences between the Northern and the Southern branch in great detail as well as a lot of parallels to Western magical ideas. We'll go into detail about certain shamanistic practices as the base of an original Chinese magical system and Jason will explain the practice of Qi Gong versus Neigong and the aim of the latter which is quite in harmony with a lot of Western alchemical and spiritual practices. We also touch on the importance of the landscape surrounding the magician and the inclusion of ancestors for his workings. Of course, Jason's two books ‘Thunder Magic' and ‘Fox Magic' that have already been published with Mandrake will be an important topic and he will open up on his motivation using a certain terminology in his writings. Both books are highly recommended for anyone who wants to learn more about Chinese magical concepts in a profound yet quick and accessible way and the next book in his series will be ‘Practical Chinese Magic' which should be out soon, also published by Mandrake. In this most recent book Jason aims for covering the fundamentals that a skilled Western magician can take out and apply to his practice. Music played in this episode Exist Trace (イグジストトレイス, Iguzisuto Toreisu, stylized as exist†trace) is a Japanese visual kei rock band, consisting entirely of female members. The members originate from Tokyo, and initially formed in June 2003. The founding members are Jyou, Naoto, and Mally, who met Miko and Omi after placing an advertisement for guitarists. To date, Exist Trace has released four albums, eight EPs, and nine singles.In addition, the band has appeared on eleven compilation albums and three omnibus DVDs, plus their self-released 2012 concert DVD Just Like a Virgin. Exist Trace made their U.S. debut at Sakura-Con 2011 in Seattle, Washington. On June 15, 2011, they made their major label debut on Tokuma Japan Communications with the EP True. Their song "I Feel You" was featured in Nadeshiko Japan's official 2012 guidebook DVD...
We had the pleasure of interviewing Ultra Q over Zoom video! Oakland-based four-piece band Ultra Q have released their new EP Get Yourself A Friend today (via Royal Mountain Records). Fronted by Jakob Armstrong and featuring brothers Enzo and Chris Malaspina as well as Kevin Judd, the new EP was co-produced by Armstrong and Martin Cooke (Of Monsters And Men, Death Cab For Cutie, Destroy Boys) and features songwriting from Stefan Babcock, lead singer of PUP. Click HERE to buy/stream Get Yourself A FriendClick HERE to watch the video for “Get Yourself A Friend” Ultra Q have also released the official music video for the title track today which was shot by Pennacky, the Japanese director behind all of the music videos for 88Rising's soundtrack for Marvel's Shang-Chi and the Legend of Ten Rings. Upon meeting Armstrong and Pennacky immediately connected on their love of The Cure and a deep-cut video that inspired Pennacky to attach the camera to a rope for the new visual. Pennacky is also an avid fan of the Ultraman Sci-Fi series and drew from the original plot to shape the story of the video. Opening double-shot “Pupkin” and “It's Permanent” soar to the heights of Ultra Q's powers in much different ways; the former a black-clad romp through a rainy graveyard, the former pushing straight to the clouds with its soaring chorus. “Straight Jacket” veers pleasantly close to the jangle-pop of the Go-Betweens. “Bowman” features guitars like cats getting into a scratch-fight while an astoundingly metronomic drumbeat is played live rather than punched out on a beat pad. Closing the EP is its title track, an affecting end credits anthem full of nostalgia and a twinge of regret. On the song, which Babcock helped to arrange, Armstrong shares, “I think this track sums up what this EP is supposed to be, a coming-of-age farewell to our youth. It's about being young and in love. Being reckless, and overstimulated. Feeling like the tragedies in your life are permanent and without any direction. We've grown up, even if it's ever so slight.” As a whole, Get Yourself A Friend marks the synthesis of a songwriter's vision and his band's ability, forged through an invisible existential threat and an ever-changing world, eager to show what they've found while we were all inside. Ultra Q's previous EPs, In a Cave in a Video Game and We're Starting To Get Along, saw the band gain praise from the likes of Rolling Stone, NME, and Vice, in addition to leading to tours with The Regrettes, Hockey Dad, and Bad Suns. Jakob Armstrong—youngest son of Green Day frontman Billie Joe—began playing guitar at seven years old and honed his craft privately until about sixteen, playing in bands in and around Oakland after meeting friends with like-minded tastes in music. Soon enough, with the memories of Ultraman action figures fighting in his mind, he and a group of friends he cultivated from those years playing around and pouring over records, formed Ultra Q. The band will play Atlanta's Shaky Knees Festival in Spring 2022. We want to hear from you! Please email Tera@BringinitBackwards.com. www.BringinitBackwards.com #podcast #interview #bringinbackpod #UltraQ #Punk #EastBayPunk #zoom Listen & Subscribe to BiB Follow our podcast on Instagram and Twitter!
For the past 25 years Marc Brackett, Ph.D has been researching and writing about emotions and running around the world talking to people about their feelings. Marc Brackett, Ph.D., is the founding director of the Yale Center for Emotional Intelligence and a professor in the Child Study Center, Yale School of Medicine at Yale University. “Our emotional state is one of the most important aspects of our lives. It rules everything else. Its influence is pervasive. Yet it is also the thing we steer around most carefully. Our inner lives are uncharted territory even to us, a risky place to explore. Our lives are saturated with emotions-sadness, disappointment, anxiety, irritation, enthusiasm and even tranquility. Sometimes-often-those feelings are inconvenient. The irony, though, is when we ignore our feelings, or suppress them, they only become stronger. " Key poiints: Why emotions matter? (5 key areas) The differnce between emotions and feelings Incidental feelings vs integral Charecterisitics of an emotion scientisit The RULER What's a Mood Meter GET HIS BOOK Permission to Feel: Unlocking the Power of Emotions to Help our Kids, Ourselves, and our Society Thrive OTHER EPISODES YOU MAY LIKE 262:When Your Needs are Not Met 261: How to Master Difficult Feelings 216: Childhood Emotional Neglect 129: How to Listen to Children's Big Feelings 178: Raising Emotionally Healthy Kids Emotion Series from Eps. 148-158 (Anxiety, Anger, Boredom, Fear, on Tears and Crying) BECOME A SUPPORTER OF THE SHOW 1. With your support we can continue the production of the podcast uninterruptedly. You can choose a level of support on Patreon.com by becoming a patron. 2. One time donations are also deeply appreciated. Give from the heart now. FULL SHOW NOTES www.authenticparenting.com/podcast ABOUT ME I help overwhelmed, frustrated parents who want to parent differently than their parents, make sense of their early childhood experiences, connect to their authentic self and their children on a deeper level, reduce stress, bring more ease, calm and joy into their lives by yelling less, and practicing non-punitive discipline. WORK WITH ME Listeners of the podcast get 10% on my coaching services. I would be thrilled to support you in your parenting journey! Click here to get started with my Introductory (3 Sessions) Package or REAL Change Package - 6 Private Coaching Sessions-worldwide! :) Court-Ordered Parenting Classes (in person NJ, NY,and PA residents only) YOUR FEEDBACK IS VALUABLE! Do you have a comment, question, or a takeaway about this episode or the podcast in general? USA listeners call 732-763-2576 right now and leave a voicemail. International listeners use the FREE Speak Pipe tool on my website. Add your voice. It matters! Email: info@authenticparenting.com SUBMIT YOUR PARENTING QUESTIONS TO BE ANSWERED IN THE SHOW: Voicemail: 732-763-2576 Speak Pipe for sending audio messages Email: info@authenticparenting.com CONNECT WITH ME ON SOCIAL MEDIA Authentic Parenting on Facebook Instagram NEED PARENTING SUPPORT? Join the Authentic Parenting FREE online community Thanks for listening! With gratitude, Anna Seewald, M.Ed, M.Psy Parent Educator, Keynote Speaker, Author www.authenticparenting.com
A show of MOST of the nominees for the Manifesto Awards so far for 2021. The Awards show is the 2nd Wednesday in January, which will be Jan 12th, 2022. If there are any songs, singles, EPs, albums,... Real Punk Radio podcast Network brings you the best in Punk, Rock, Underground Music around! From Classic Oi!, Psychobilly and Hardcore to some Classic Rock n Roll and 90's indie Alt Rock greatness!! With Tons of Live DJ's that like to Talk Music From Garage Rock, to Ska.. We are True MUSIC GEEKS!
A show of MOST of the nominees for the Manifesto Awards so far for 2021. The Awards show is the 2nd Wednesday in January, which will be Jan 12th, 2022. If there are any songs, singles, EPs, albums, reissues, etc., … Continue reading →
Mari Fong interviews Katelyn Tarver, singer-songwriter and actress, and Dr. Adi Jaffe, psychologist, addiction specialist, and author of The Abstinence Myth. Katelyn Tarver shares her story and solutions for living with anxiety and self-doubt. Katelyn released 6 EPs of her own music before winning NBC's "Songland" in 2019. Her song, "You Don't Know" captures the feeling when you're not okay, and songs off her new album "Subject To Change" have the same emotional honesty and vulnerability.Next, we have Part 2 of the interview with expert Dr. Adi Jaffe, Ph.D, psychologist and author of the book,The Abstinence Myth. Dr. Jaffe shares the importance of finding the root causes of addiction and how therapy can be essential to longtime recovery and sobriety. He explains his unique approach with the IGNTD program.“Be brave, ask for help, and be persistent in finding the mental help that you need.” For free and affordable solutions for mental health and addiction recovery, visit: http://checkyourheadpodcast.com/* Donate to our mission at checkyourheadpodcast.com or on our patreon.com page. Every dollar is appreciated, every listener is appreciated.THANK YOU for following us on social media @checkyourheadpodcastWatch and subscribe to our YouTube Channel: checkyourheadpodcast.youtubeSupport the show (https://www.patreon.com/checkyourheadpodcast)
Eps. 67: Today on Two Mics Up we are talking academics, STEM, getting over stumbling blocks and weather! We have the opportunity to speak with award winning meteorologist Monique D. Robinson of WFMY TV out of Greensboro North Carolina. Monique is a Jersey native, making waves in the broadcast and journalism fields, but she is deeper than what you see on the surface. Although you see her on TV, it's her work in the community and behind the scenes that truly stands out. Tune in, and enjoy the conversation with Our Weather Girl! Featuring: Monique D. Robinson - Meteorologist at WFMY News 2 Greensboro North Carolina --- Support this podcast: https://anchor.fm/twomicsup/support
Hailing from Philadelphia, America's City of Brotherly Love, Ryan Tennis' music is all about dismantling boundaries and bringing people together. Genre-defiant by nature and with diversity at its core, his rousing songs are infused with the rhythms from the many countries he's visited during his extensive tours. While his performances are dynamic and danceable, Tennis' voice and songs have a disarming sweetness that lowers your defenses and lets you breathe easy. A singer-songwriter and guitarist, Ryan Tennis' style bares a strong influence from the Folk and Rock he grew up with (Simon & Garfunkel, The Beatles, Crosby Stills, Nash & Young), a connection with roots soul music that grew in his youth (Bill Withers, Otis Redding, and Sam Cooke), and the energy and rhythms of Colombia, where he has toured and collaborated with some of the country's finest artists. Despite a life that now circulates around music almost entirely, Tennis admits he was a late bloomer when it came to songwriting. Sports occupied much of his time during his teens and into college, playing as a 1AA All-American defensive lineman at Davidson College in North Carolina until the age of 22. That intensity and power that he channelled for football still comes through in Tennis' live performances. Over the last 12 years, Tennis has played 100-200 shows a year and pulled off countless independent tours with shows in the US, Argentina, Colombia, Peru, Costa Rica, Mexico, Ireland, Switzerland, Germany, France, Austria, the Netherlands, Denmark, Italy, Spain, Thailand, and Australia. Since then, Tennis has also released four full-length LPs and two EPs, has fronted a 10-piece "Graceland'' band with the Grammy award-winning South African bass player Bakithi Kumalo, collaborated with Latin Grammy winning artists Nidia Gongora and Hugo Candaleria, and regularly toured South America with Latin Grammy-nominated group "El Caribefunk”. Additionally, he won the Philadelphia Songwriters Project, was selected as a finalist in the International Songwriting Competition, and helped found “Sancochofest” in the City of Tuluá, Colombia. In his hometown of Philadelphia, he curates and hosts “Tracks at the Vale,” a vibrant concert series on the stage he built in his backyard, where the music and the crowd echo the warmth and diversity he has fostered in his music. “Everyone's struggling these days in their own way, including me” Tennis says. “The best way I've found to feel that joy, that flow, that freedom from worry, is when I'm performing, when I feel like I'm channeling something big. When I'm in that place I can open up my own groove, and open it up for other people too.” Ryan Tennis has achieved so much during his time in music and shows little sign of slowing down. His forthcoming single, 'Alligator' is scheduled for release in early September 2021; a taste of what's to come from his forthcoming album later in the year. https://www.ryantennismusic.com/
It's amazing how what was supposed to be a one-time thing has now become a regular series, yes the Cha Cha EP Compilation Series was supposed to be a one-time episode but you guys kept requesting more EP reviews and here I am with the Cha Cha EP Compilation Series Vol 5. Today I would be talking about four EPs from Buju, Ladipoe, Sess and SperoachBeatz but before then listen to this Click on the play button to listen Here are links to the EPs 1. LadiPoe –Providence https://open.spotify.com/album/6y0Jfh7dZgzKcxM2hP7PgF?si=aRKnAhNZRImU491jNYBpRw 2. Buju - Sorry I'm Late https://open.spotify.com/album/4bwyX8dGHZk71KDKDZU04u?si=tAKCbvRTSJydqiXi-Tufxw 3. SperoachBeatz Melodies Vol. 1 4. Sess (The Prblm Kid) –Spotlight https://open.spotify.com/album/621D83S6JgxUVh5MZv6Kjo?si=M9M1b0maTcqlQEJaDs5wTQ Link to Intro and Outro Song Hafeestonova ft. Itz_Roxane x Kenna Jay x Ydiz- Cha Cha Anthem https://open.spotify.com/track/2Q7HvtfNmS8tClefiXj6jX?si=e00e2932ed3d4579 --- Send in a voice message: https://anchor.fm/hafeestonova1/message Support this podcast: https://anchor.fm/hafeestonova1/support
S2 Ep.25 #OneMicNiteArtistSession:Christopher Hackett from the Punk Rock innovator band The Mob in his Studio *** Guest Subscribe/ Follow IG: @m_ o_n_k_66 on Spotify: @Monk & The 66 ***Hailing from the Band that set the precedence for Punk Rock Music as we know it, "The Mob' member Christopher Hackett is on the scene as a solo artist with a music direction that easily translates to all listeners. In the OneMicNite Artist Session, we go inside the home studio post-pandemic and Award winning Host Marcos Luis talks interviews and finds the story behind the music. **** —-Bio: Christopher was born and raised in Queens NY. At 16, he met Jack Flanagan, guitarist for the seminal NYHC pioneers, The Mob. Starting out as a roadie, Christopher soon took on bass duties in 1985 when original bassist Jose Gonzalez left to join the HR band (legendary vocalist of the Bad Brains). Christoper recorded the album We Come to Crush with The Mob and played his first gig with teh Mob at CBGB's. Christopher toured with the Mob on and off for the next 35 years, usually as a 5-piece with Christopher on guitar and with Jose returning on bass. In 2012, the Mob released the single “Back to Queens / Thats It”, both written by Christopher and vocalist Ralph Gebbia. Christopher played his last gig with The Mob at Generation Records in NYC in the winter of 2017, before relocating to California. In the early 90's, Christopher recorded and toured with Juicemen, releasing 2 EPs produced by Sean Slade (Radiohead, Hole, Dinosaur Jr), and engineered by Dave Dominich (Lenny Kravitz). In California, Christopher started the Monk & The 66 project. Initially starting as demos, the project began to take shape during 2020, and in 2021, Christopher Monk released the first Monk & The 66 single, Isolation Station. He quickly followed up with “Riding with the Ghost”. Taking on an obscure Allen Toussaint single from 1966, Christopher reworked and released Omar Khayyam which crystallized the Monk & The 66 sound with tight grooves. scratchy guitars, deep bass lines, topped of by Christopher's gravelly vocals, bringing to Tom Waits or Robbie Robertson. In October 2021, Christopher released his most compelling and autobiographical song to date, Like a Man on the Moon. Featuring Christopher's searing slide guitar and dub style bass, Like a Man on The Moon tackles Christopher battle with depression and healing journey. As 2021 comes to a close, Christopher is putting finishing touches on his last single for 2021, Pain of Love. *** Through his prolific career in the music scene of NYC in the days that started a music movement, he has now launched more solo projects to be inspired and re-inspire a new generation of listeners. In this episode we get a chance to hear two new projects upcoming while in the Studio. **Follow/Subscribe to the Show: IG/Fb/Twitter/TikTok/Tumbler/Youtube : @OneMicNite www.OneMicNite.com ***Follow/Contact: Host IG/Fb/Twitter @MarcosLuis www.MarcosLuis.com **OneMicNite has been a platform for indie artist since 2006. Now virtually with its creator Marcos Luis it receives The Citi Artist Corps Grant to help continue to support indie artists Internationally. If you would like to help us, pleas go to : www.Anchor.fm/onemicnite and donate. Thank you for your continued support. --- Support this podcast: https://anchor.fm/onemicnite/support
On today's episode, I talk to musician Cedric Noel. Montreal-based artist Cedric Noel has spent the past decade creating music informed by his unique worldview: He was born in Niger to Canadian and Mozambican/Belgian parents, spent his upbringing around the world, and is currently based in Canada. During this time, Cedric has released a number of critically praised full-length albums, EPs and collaborative works of his own, while also playing bass for acts like Ada Lea and many others. His latest album Hang Time is out now on Joyful Noise, and it's great! This is the website for Beginnings, subscribe on Apple Podcasts, follow me on Twitter.
Bring Back My CURDS! We tawkin' Canada's Drag Race Season 2 Eps 3 & 4 with Mano Agapion & Oscar Montoya! WOW! Listen to these h8ful gays talk about that scary parody, the CHOICES of snatch game, & the truly UNTOUCHABLE runways! Go watch the eps on Wow Presents Plus! KIKI with us at Drag Her's IG! PREPARE TO GAG, WHORES!!!!! PROPS TO YA, DWOTUR! BUY OUR MERCH! 50% of everything we make goes to The Okra Project! If you rate Drag Her 5-stars on Apple Podcasts & leave us ANY UNPOPULAR RPDR OPINION, we'll discuss it on the pod!!!!! DO IT!! AND PLUS AND!!! Go to our IG to watch our super special IG LIVES covering Drag Race UK! Black Lives Matter. DONATE NOW! Listen to Drag Her on Stitcher, download the app, or get more info at stitcherapp.com/dragher! Get more Mano on We Love Trash & Podcast Killed The Video Star! Drag Her IG: dragherpodcast Theme Song: Twinkids (@twinkidsmusic) Art by Jack Manion (@jackmanion) Advertise on Drag Her via Gumball.fm See omnystudio.com/listener for privacy information.
Anomalie is the live electronic project of Nicolas Dupuis, a keyboardist and producer based in Montreal, QC. Rising to worldwide fame after the release of his two EPs, Metropole Part I and Part II, Dupuis begins the next stage of his career with his debut single, “Bond,” off his upcoming debut full-length album, Galerie, set for April 2022. This new chapter includes the announcement of the Galerie World Tour, featuring new arrangements with the Anomalie Live band, coming to 22+ cities all over the globe. Galerie marks brand new sonic directions and for the first time ever, vocal collaborations - all the while staying true to the sound that has built a worldwide fanbase and remains unmistakably Anomalie. His music innovatively combines cutting-edge electronic production, jazz, and classical harmonies, virtuoso keyboard skills, and an undeniably raw funk groove connecting it all together. This places his career in a singular position. His public cosigns include an eclectic mix of music heavyweights (Charlie Puth, Chromeo, D Smoke, and Snarky Puppy), and his fanbase is a mix of the new jazz scene (Louis Cole, Keifer), the soulful beats scene (FKJ, Masego), and the post-dubstep electronic scene (Griz, Odesza). Dupuis has a lot to reflect upon the success that got him here. By the end of 2020, Anomalie sold out two world tours (North America, European, and Asia) with his intricate 4-piece live band, grew his online following in the millions across social media, and performed at the likes of Red Rocks, Montreal Jazz Festival, and Electric Forest Festival. Most impressively, he's achieved all of this as an independent artist. Anomalie Links: https://anomaliebeats.com/ Mr. Bill's Links: Patreon: https://www.patreon.com/mrbillstunes https://live.mrbillstunes.com/ https://discord.gg/ySjhgWQ https://mrbill.bandcamp.com/ https://www.youtube.com/user/MrBillsTunes Podcast Produced & Edited by: https://twitter.com/303FuMo
This interview I'm bringing to you today could have been 5 hours long because I really loved how aligned and beautifully Lou Matson speaks about channeling, trusting your journey, and surrendering. I was nodding and agreeing the whole time we talked and I know you will too! Lou is a channel for high-frequency spiritual energies, best-selling co-author, creator and host of the Mundane to Magical Summit Series, and a catalyst for transformation. She serves the global multi-dimensional community by helping people fulfill their soul's purpose mission and evolve on their spiritual paths of soul embodiment and sovereignty. Lou has been a channel her whole life, but after realizing her parents wouldn't approve of her gifts, she boxed them up as long as she could. After her parents passed away, the floodgates opened, and she made the commitment to stop hiding and put her gifts to the service of the highest good of all. She also did a channeled meditation for us, so make sure you listen to the whole episode! In this episode you'll learn about: Channeling and tuning in to get clearer messages Answering the Universe's nudges The vital part that trust and surrender play in living in sovereignty 03:18 - the spiritual energies Louise speaks with 12:05 - her experiences and ascension journey 20:56 - about trust, faith and surrender 28:47 - a story about divine timing 32:04 - importance of awareness and what it is 39:55 - healing meditation begins Related episodes: Ep 55: Tips, Tools and Techniques, Oh My! https://www.marilynalauria.com/eps-055-tips-tools-and-techniques-oh-my/ Eps 44: That Lamp Just Spoke to Me https://www.marilynalauria.com/eps-044-that-lamp-just-spoke-to-me/ Ep 27: Is That My Guide's Voice or Mine? https://www.marilynalauria.com/eps-027-is-that-my-guides-voice-or-mine/ ***************************** Don't forget new episodes come out every Thursday! Follow and rate the podcast on Apple Podcast. Help us spread the word by sharing this episode with a friend. *************************** If you have any questions for me, email whocanitbenowpodcast@gmail.com Get your Guide at https://marilynalauria.com/guide _______________________________ Follow me on social: Facebook: https://www.facebook.com/marilynalauria1 Instagram: https://www.instagram.com/marilynalauria
Janet Varney is an Emmy-Nominated actor, comedian, writer and producer. In the animation world, she is lucky enough to be the award-winning voice of Korra on Nickelodeon's critically-acclaimed standout hit “The Legend of Korra,” a role for which she continues to be invited to comic cons to give sweaty handshakes the world over. She can also be seen as the entitled and bitchy Becca on FX's (via hulu) “You're the Worst” (named as one of the last decade's best comedies), and fighting dark forces alongside John C. McGinley as Evie Barrett on IFC's (via hulu) “Stan Against Evil.” Her own podcast on the Max Fun network, The JV Club with Janet Varney, has been going since 2012 and features almost 400 interviews with celebrities about their awkward teenage years. She co-programs comedy for Outside Lands music festival and is co-founder/creative director/producer of one of the largest and most acclaimed comedy festivals in North America, SF Sketchfest: the San Francisco Comedy Festival, now in its 20th year. http://janetvarney.com/ Episode co-hosts: FRANCES LUKE ACCORD When Nicholas Gunty and Brian Powers put their songs and their voices together, there is a delicate magic that commands the room to attention. The duo is known as Frances Luke Accord, and they are what NPR's Mountain Stage calls “the definition of lean-in music.” Their soft, contemplative vintage of indie-folk gestures toward a timelessness that honors the Simon & Garfunkel comparisons but pushes beyond into the world of Bon Iver, Jose Gonzalez, and progressive folk music. Both raised in South Bend, IN, Gunty and Powers met and began performing together during their time at the University of Notre Dame. Their first release, 'Kandote', was an intercultural collaboration with the Barefoot Truth Children's Choir in Uganda, a not-for-profit effort which provides ongoing support to the choir to this day. Relocating to Chicago in 2013, the duo honed their songwriting craft while releasing two more self-produced EPs, laying the groundwork for their breakthrough debut LP, 'Fluke'. This immersive, philosophically rich album set them off on their first national tour, which included support dates with Anais Mitchell, Darlingside, and The Ballroom Thieves. The duo's 2021 release, the Sunnyside EP, offers a glimpse into the larger body of work Frances Luke Accord have been developing over the course of the pandemic. More to come soon. https://franceslukeaccord.com/ LYRICS to Afterlife: As long as you're by my side I will make you dinner in the afterlife Live in our after world Stringing jewellery of gold and pearl Some bonds don't break I come to nourish you with my hands Make you a sculpture in the sand Hands that work, hands that tire We form the shape but the shape expires You know I worked for all these years Trying my hardest at my life career We've been witness to joy and pain But the world we left was the world we gained We're so different you and I In a way we never saw eye to eye Despite the loss that set me free In a way you're maybe still guiding me Some bonds don't break We all need shape As long as you're by my side Will you make me laugh in the afterlife? Long as our long dark night You can lead me on to the morning light --- Send in a voice message: https://anchor.fm/podsongs/message
Third quarter earnings are heading into the home stretch in Europe and the UK, but while a solid number of companies have beat earnings estimates, market reaction has been a bit curious.----- Transcript -----Welcome to Thoughts on the Market. I'm Graham Secker, Head of Morgan Stanley's European and UK Equity Strategy Team. Along with my colleagues, bringing you a variety of perspectives, I'll be talking about the emerging read on third quarter earnings for the region. It's Tuesday, November the 9th at 3pm in London.Europe and the UK are now more than halfway through third quarter earnings season, and so we're far enough along to form a view on how this quarter's earnings are playing out. And while earnings have been largely solid, price movements on the day of earnings announcements, and in the days following, have been a bit curious. But I'll get into that in a moment.As it stands, third quarter earnings appear on track to deliver a solid number of companies beating earnings per share estimates. As of yesterday, 55% of European companies have beaten earnings estimates, while 23% have missed, leaving a 'net beat' of 32%, which is twice the historic average. If this holds, it would put third quarter results on track to deliver another strong upside surprise, albeit slightly below the pace seen over the last few quarters. Taking it to the sector level, we find that the strongest breadth of earnings beats are coming from Financials and Energy. On the flip side, Communication Services, Healthcare and Industrials have delivered the smallest breadth of beats so far.In addition to a healthy number of companies exceeding estimates, we are also seeing a beat in terms of the aggregate amount of European earnings overall, with weighted earnings per share currently beating consensus by about 10% for this quarter. This good news on earnings has driven a fresh bout of upgrades, which should reduce investor concerns around the risk to corporate profitability from ongoing supply chain issues and high input cost inflation.All that said, earlier, I mentioned a bit of curiosity about price reaction. Typically, if a company beats earnings per share estimates, you might expect to see better stock performance that day or in the days that follow. And of course, the opposite is true for companies who miss estimates. However, a key talking point during this results season has been the surprisingly disappointing price action, even for companies who beat expectations.Currently, the gap between the outperformance of earnings beats on the day of results relative to the underperformance from earnings misses has been very negatively skewed in a historic context. In fact, this negative skew to price action is close to a record low going back to 2007. On our data, we calculate that EPS misses have, on average, underperformed by 1.6% on the day of results, whereas companies that beat estimates have been broadly flat in relative terms. Hence, while the third quarter has been a solid earnings season overall, the hurdle rate to positively surprise the market is currently quite high.In our opinion, this reflects investors' uncertainty about the future earnings outlook and whether company margins will face a delayed hit in the quarters ahead. While understandable, we think this caution is overdone. Rather, we expect Europe's earnings dynamic to remain positive into 2022, with companies benefiting from a strong external demand environment and a record level of pricing power.Thanks for listening. If you enjoy the show, please leave us a review on Apple Podcasts and share Thoughts on the Market with a friend or colleague today.
At this point in 2021, we thought there would be several new pieces of diabetes technology on the market. COVID delayed several FDA submissions and approvals so where do we stand? Stacey sits down with Kamil Armacki, AKA Nerdabetic, and Chris Wilson to talk tech. Both Kamil and Chris keep a close eye on everything from filings to clinical trials to investor calls and neither is affiliated with any diabetes company. There is also video of this if you prefer to watch over on the YouTube channel. Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! ----- Get the App and listen to Diabetes Connections wherever you go! Episode transcription below Click here for iPhone Click here for Android Stacey Simms 0:00 Diabetes Connections is brought to you by Dario Health. Manage your blood glucose levels increase your possibilities by Gvoke Hypopen the first premixed auto injector for very low blood sugar, and by Dexcom, take control of your diabetes and live life to the fullest with Dexcom. This is Diabetes Connections with Stacey Simms. This week, I wanted to try something a little different as we enter the end of 2021. And look ahead to next year, I thought it would be a good time to sort of take stock of diabetes Technology. Welcome to another week of Diabetes Connections. I'm your host, Stacey Simms. And we aim to educate and inspire about diabetes with a focus on people who use insulin. And while this community likes to say we are not waiting, frankly, there was a lot of stuff that we are waiting for right now, I asked a couple of friends who really have their finger on the pulse of this stuff to come on and share their thoughts. The only problem we really like to talk. So this is a longer episode than I expected. And frankly, it's not just that we'd like to talk there's just a lot of technology that we are waiting for. So to that end, I'm just going to jump right in, we'll do the quick add that we always do at the top and then we'll get to the panel. There is also video if you prefer to watch our conversation that's over on the YouTube channel. I'll link it up in the show notes but we are not showing any product. So it's really just about whether you prefer audio or video. Alright, Diabetes Connections is brought to you by Dario health. And the bottom line is you need a plan of action with diabetes. We've been lucky that Benny's endocrinologist has helped us with that and that he understands the plan has to change as Benny my son gets older, he wants that kind of support. So take your diabetes management to the next level with Dario health. Their published studies demonstrate high impact results for active users like improved in range percentage within three hypoglycemic events. Try Dario's diabetes success plan and make a difference in your diabetes management. Go to my dario.com forward slash diabetes dash connections for more proven results and for information about the plan. And as always, this podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. All right, welcome. We're trying something new on Diabetes Connections. And that is the first of its kind kind of tech panel. And I am joined in this conversation by Chris Wilson and Kamil Armacki . And these are two guys that I'm gonna let them introduce themselves a little bit, but that I follow for technology news, as well as for some analysis. So thank you both for jumping on with me. You're not industry people. But let me ask you to kind of describe yourselves first, Chris, you are somebody that I always turn to for the insight and information about technology. But this is not what you do for a living? Chris Wilson 3:00 No, not really. I sort of jumped into the online diabetes online community when I reached a point where I had access to insurance and could actually look at diabetes technology because it became affordable. And at that point sort of started jumping into a lot of the groups and online discussions tried to figure out what I was interested in for myself at the time. And then over time, I wound up being asked to join the admin team of a couple of the bigger Facebook groups getting involved on Twitter and other platforms. And so now i is part of that role. I sort of find and analyze listen to the investor calls that the companies do, you know, sort of keep an ear to the ground here what people's sales reps and endos are whispering about to to their patient populations and glean some information from that. I've also been a frequent participant in research, especially in clinical trials. I was in the clinical trial for the G6 that prove that acetaminophen didn't interfere with it. I was in the clinical trial for the Xeris Gvoke. I was in the clinical trial for the Ilet, which is still apparently ongoing. I've got a fair amount of experience for playing with stuff that isn't necessarily out yet. And sort of seeing things from a different perspective than just the end product that people see when they finally get a prescribe from their doctors. Stacey Simms 4:23 That's great and comedic view or better known as Nerdabetic. On social media, many people probably recognize your Omnipod. Those are Omnipod pods lit up right behind you. Kamil Armacki 4:34 That is absolutely right. That is 550 inch LED Omnipods. Most of them this is very DIY. Most of them actually placed with LED lights and painted and we saved them on a temporary wall kind of thing and we glued them off. So we had this is one of the proudest things I've ever done as Nerdabetic I also can't really take credit my dad that 95% I only paid a couple of walls, and I feel like I'm taking all the credit. So massive shout out to him. Stacey Simms 5:07 I love it. I love it. And as Nerdabetic, you are known for interviewing CEOs getting all sorts of tech information out there. And we'll probably mentioned this at least once later on, you do a lot of both, you do some 3D printing, right to see what the items might look like. Yeah, so Kamil Armacki 5:23 I've been running my YouTube channel for I think four years at this point, just when I started university, and I just graduated this summer. So it kind of it was over four years ago. So you just been trying out different things within within that channel. One of them was 3D printing. I'm absolutely fascinated by that technology. I don't own a 3D printer. But I think it is a very interesting way of giving an idea, a bit of a tangible feel to it. So for doing that, and all of those things they mentioned. And most recently, I had the honor of speaking to some pretty pretty important people in the industry to see what's been happening over there as well. Stacey Simms 6:01 Cool. All right. And Kamil is in the UK, obviously, you sound like you're based in the UK, but you are there now, which means some of this discussion will include information from the US FDA, or at least we're gonna speculate about that same thing, European CE mark, but some differentiation of products there. But I just thought it'd be fun to talk to you guys. So all right, we've got it out there. And I'm a diabetes mom, I read stuff, I listen to stuff, I don't think quite as much as Chris, or Kamil, but that's my knowledge base. So just to be clear, nobody who works for the FDA, nobody who works for diabetes company, we are just observing and birth speculating, which I think would be some pretty fun and interesting conversation we'll see. So let's start by talking about what is in front of the FDA right now, because this year, and last year had seen some big delays due to COVID. So we're waiting. I mean, it's been a long time. Let's start with Omnipod 5. And that is, of course, still as we are speaking, I mean, who knows what will happen today or tomorrow, but it is still in front of the FDA. But what's interesting is when they submitted and Phil, I know you talked to their CEO recently I talked to her I believe right before they submitted, it was going to be very different from the other commercial hybrid close loops in that the range was going to be lower. In other words, your blood sugar range, initially, I believe, was supposed to be able to get below 100 As a set point, but now it's 110. And they do have all sorts of really interesting other features. What did Shacey Petrovic, the CEO of Omnipod share with you recently, when you talk to her anything changed, or anything that stood out to you? Kamil Armacki 7:36 Yeah, so I've spoken to her a couple of weeks ago at this point. And the product that they've submitted to the FDA, for my understanding, has a target glucose, which goes as low as 110, and can be customized up to 150 milligrams per deciliter. In terms of the actual product, I think I'm very excited about Omnipod 5, because it will be the first product, the first pump, which actually talks directly to the Dexcom G6 continuous glucose monitor. So there'll be no need to carry a physical controller, which obviously, I think makes sense for a product like Omnipod because you know, you wear it on your body. And so it will connect directly in terms of actual updates to submission as of a couple of weeks ago, she said they still expect an A by the end of the year, with a limited release in the US. And during that interview, which was slightly kind of European focused. We talked about many things including Omnipod on the runway during Italy's Fashion Week in Milan. But she also mentioned that they are hoping to bring that technology to their to Europe to the UK, once they get their FDA approval. Stacey Simms 8:48 When you said the first one or the only one do you mean in the UK? Because we've got Dexcom talking to Tandem, at least here in the States. Kamil Armacki 8:55 First one where you don't need so where the pod talks wearable talks throughout behind okay. Yeah, I thought directly to the G 610. Stacey Simms 9:05 Is control IQ approved in the Kamil Armacki 9:06 UK stupid question. Yes, we have. So at the moment, we have control IQ and seven ATG which we will I'm sure mentioned Oh, yeah. Okay. I didn't come EPS actually. So we have three other countries across Europe. They have other systems like dialup as well, France, Germany, but we don't have that one here. Yeah. Hashtag Brexit. Stacey Simms 9:28 I was gonna say show off, but then right. It's not in the UK. Lots of and there's other systems coming to that we may get to, Chris, anything that you have heard over the last year in terms of Omnipod? Five. I mean, I just feel like we're kind of waiting. Chris Wilson 9:40 I mean, just from my view on the outside. I think that insolence estimates of hopefully getting it before the end of the year, probably right. I know that it did qualify as a breakthrough device. So it's supposed to have a faster review at the FDA, but we're still dealing with the COVID backlog with all kinds of stuff. For me, there's things that we probably expected six months ago, there's still pending. And I know there's always rumors circulating that this got approved, but it hasn't been released yet. And so half the time I'm going and checking the FDA database for what approvals were announced in the last week. Kamil Armacki 10:16 Only Chris does this kind of stuff. Stacey Simms 10:20 I did have an interesting question from a listener who was talking about Okay, so as we're taping, Dexcom g7 has not yet been submitted to the US FDA, it has been submitted in Europe. And her her thought was like, Oh, my gosh, if Omnipod has been sitting there all this time, and Dexcom hasn't even submitted, how much longer is it going to take? And my point to her was, it's not as though Omnipod and these other submissions are just sitting in a file cabinet. Right? I mean, they are actively being looked at. You're both nodding. Can you tell me a little bit about what we know I mean, these submissions again, they don't just land on a desk and then one day someone opens them and rubber stamps them. Back to our conversation in just a moment, but first Diabetes Connections is brought to you by Gvoke Hypopen and you know, low blood sugar feels horrible. You can get shaky and sweaty or even feel like you're going to pass out there are a lot of symptoms and they can be different for everyone. I am so glad we have a different option to treat very low blood sugar. Gvoke Hypopen is the first auto injector to treat very low blood sugar. Gvoke Hypopen is pre mixed and ready to go with no visible needle before Gvoke people needed to go through a lot of steps to get glucagon treatments ready to be used. And this made emergency situations even more challenging and stressful. This is so much better. And I'm grateful we have it on hand, find out more go to diabetes connections.com and click on the Gvoke logo. Gvoke shouldn't be used in patients with pheochromocytoma or insulinoma visit Gvoke glucagon.com/risk. Now back to Chris answering my question about FDA submissions. Kamil Armacki 12:00 Yeah, so for the pandemic, the main reason as to as to why we have a backlog is that regulators that used to regulate that were in charge of regulating medical devices like continuous glucose monitors, hybrid closed loop systems. And this is across actually Europe and US it's very similar, simply because of the pandemic, they were actually responsible for overseeing all of the medical queries related to the pandemic from, you know, vaccines emergency authorizations. So that's what we call when a product is used in a slightly different way to kind of simplify it. And so using a CGM and hospital was a good example of that we seen an emergency authorization of that, so they've kind of, you know, dos thinks took priority. So too, you know, that's where we have a backlog, but now they from my understanding, kind of back on on track, and, you know, four hands on that backlog, working their way through it. Chris Wilson 12:57 There's just only so many people to do the work. And I mean, even when stuffs in development, there's always a lot of back and forth between the company that's developing it and the FDA, what are you going to require us to do, and so then they alter the product design sometimes to make it fit what the FDA wants, and that can even go into is as deep as the training modules. And the other information that gets given to patients when the product is prescribed, they're looking at all of that they're looking at human factors testing are people you know, able to follow the directions and use it the way that it's intended to be used, are they going to do something stupid and mess it up? They're looking at all of that. And then they're going through all of that data on all the different aspects of the devices and needing to decide, okay, is this safe enough to actually be effective? And there are different standards in Europe versus in the US? The FDA has much higher safety thresholds, whereas the European standard is basically does it do what it says it's going to do? Kamil Armacki 13:58 And just to close up Omnipod 5, I think FDA has added it Chrissie would agree this is just my personal opinion. I think FDA has been pretty scared of going to full control. And the biggest today there isn't an insulin pump, which offers, you know, remote bolus capabilities. And that's part of Omnipod 5, you know, that's what they've submitted to them. So, you know, my speculation would be that if actually they didn't submit full control within that first submission, maybe we already you know, maybe it would be here already. You know, it is an area that FDA has been very cautious about. So I guess that's a significant factor contributing to to the to the backlog as well to the delight. Stacey Simms 14:40 Well, and that brings us to our next item that's in front of the FDA. Thank you for setting that up. So Tandem has also submitted in the last year and is waiting for bolus by phone. You know, that's not the official name of it. But I agree with you. I think the FDA is really taking a very, very careful look at that bit of technology. And Tandem, you know, I believe, to your point, Chris, there has been some back and forth. You know, they don't issue press releases. Every time they asked for that, but it is happening, I think, to me, you know, as a mom of a kid who takes his phone everywhere, you know, this is something that I cannot wait for. I mean, bullets by phone just seems like such a basic capability in 2021. But of course, it's a medical device, and it's your phone. Chris, are you hearing anything? Or do you have any opinion on that? Chris Wilson 15:29 I mean, at least as far as Tandem goes, I think there's less of a risk because you still actually have the physical pump that can be used to do something if for some reason, there's a problem with the phone. If you're relying exclusively on the phone, you've got to worry about what happens if it gets lost. What happens if they're dead batteries? What happens if you unlock it and hand it to your kid to play a game and the kid goes into your bolus app and accidentally gives you 15 or 20 units of bolus while they're chatting around? I mean, all of those things need to need to be taken into consideration and mitigated as much as possible. Stacey Simms 16:01 I wonder Kamil, it's interesting to think about Omnipod because they've when I've talked to them, I've always asked like, why can't you put some buttons on the pod. And their point was, and I think this leads to Chris's point from the phone, their point has always been well, it's for safety with the pediatric patients, they don't want the kids touching the pod pressing buttons, this makes perfect sense. I was a parent of two small children, they're gonna touch everything. But it's kind of the flip side now on the phone, right. So it's an interesting look to see what you trade off in a way. Kamil Armacki 16:31 So actually, to that point, in the UK, we do have an insulin pump from rush called accucheck. Solo. And on the high level, it's kind of like a nominal pot, where the pot like device that you put on your body and actually has two buttons on it. So you can actually bolus from the patch itself. And the way they've actually engineered it is that you need to press both buttons at the same time, ensure that you don't kind of you know, lean on the you know, you could very easily lean on a button and just press it, you know, other companies have gone down that route as an Omnipod. To use that I do use a monopod. So I use Dexcom and Omnipod in a DIY setting. And yeah, I love the simplicity of it. So yeah, massive, massive fan. Stacey Simms 17:14 I think it's just all trade offs. Right. I mean, there's no perfect system, I don't think but people want to perfect. Exactly. Right. Exactly. Chris, what do you use? If you don't mind me asking? Chris Wilson 17:25 I am on a Tandem with control IQ, although I don't use it exactly as designed. I've been working with better bullet strategies and playing with the modes that have put that it gets put in be an exercise or sleep that change some of the the targets that it's trying to hit to get it to behave a little bit more like I think it should. Stacey Simms 17:47 So you're using Ctrl Q and Kamil, you're using Kamil Armacki 17:50 loop? Yeah, that's right. Yeah. on any iPhone. Yeah. Stacey Simms 17:53 All right. I don't want to move on from Tandem quite yet. But I want to talk about loop in a moment. So we've got bolus by phone in front of the FDA, which we also think could come approval could come by the end of the year, but Tandem moved their submission for TSport. Right. They were going to submit that in 2021. Chris, they are moving that to 2022. Right. Chris Wilson 18:12 That was the last that I heard. Yes. To me. Stacey Simms 18:16 I see you nodding. Kamil Armacki 18:17 Yeah, I agree that that's what my understanding of the T sport is, I think they had some communication with FDA with the phone control, which obviously plays into T sports as well. Like the point Chris was making, you know, there's no display I don't think on the although, you know, it's a patch, you know, it's kind of moving into that kind of tubeless to pipe bridge mode kind of pump. So yeah, I'm pretty sure they've decided it's pushed back further. Stacey Simms 18:48 And I should have set that up better if you're not familiar with a tee sport is a very tiny version of the T slim it is been to me it looks kind of like a beefed up cartridge and it sticks somehow to your body. There is still a tube and there is still an inset, but it kind of I don't know if it dangles off, or it sticks some I don't know. So they haven't they haven't released that I've asked a bunch of people when Lily a while ago was coming up with its own pump and it was supposed to be inset and sticky. I'm still trying to figure out how it supposed to stick to your body with an inset and they haven't really explained that. So maybe at some point, but clearly you made a 3D version of this yourself right? Didn't you like mock up a Teesport at one point and freak everybody out? Because we thought you had one? Kamil Armacki 19:27 I did. So just on that entire idea in general, there's actually a pump in it's been kind of out here in Europe and has been taken off the market and I think it's coming back at some point called collider which uses a similar idea of where three colors bright colors. Yeah, so So that's kind of it's an interesting concept because you have an infusion set and like a sticky dye upon your body. And I think it that's what Tandem has gone off as well. But yeah, I did. It's very interesting how people often will look at especially on YouTube because it's a very visual form, they will look at a picture without watching the video. And yeah, a lot of people thought I had some insider info on the T spot, which was a very interesting experiment and a lot of comments about that go like, where did you get this? And I'm like, I didn't Freeview print hello, it's 2020. Kamil Armacki 20:19 Be careful, be careful, hey, Chris Wilson 20:21 I need to take some of the blame, actually, I think for potential delays on the other Teesport, I was involved in some of the Human Factors testing. And based on some of the questions that I got asked afterwards, I think I may have done some things that they weren't expecting it some stupid things or something that was not dissipated. So that may actually be the source of some of the Stacey Simms 20:45 Alright, well, if you can't answer I understand what the heck could you have done? What Chris Wilson 20:52 I think it was, it was just in case of directions weren't necessarily clear. Or I was expecting, you know, think about this, rather than actually do it. I obviously can't go into specifics. But needless to say, I clearly wasn't doing everything that they expected as part of the tasks in the testing. So who knows that may be part of the the reason that things got delayed, but hey, if it prevents somebody else from doing the stupid things that I did, and having a problem later on, then that's actually a good thing. And actually, Kamil Armacki 21:24 I'm so glad that you did, Chris, because so many companies have tried this idea of you know, having a patch and in a short tube. So novo, they went out of business Kaleido also really struggling, we don't really know if they're gonna come back. And Tandem is now trying, they're kind of stab at it. No one has really made this idea work. So Stacey Simms 21:43 yeah, it's a good point. But one thing I do like, again, I don't have diabetes, I don't wear the devices. But the idea I like is that with an inset, you do have a choice of how it connects angled or what the cannula length is, or steel, you know, with Omnipod, or you don't have as many options in terms of how it connects. Now, many people will say to counter that, well, you have many more options of where you can put it, you know, so it really just depends on how you wear it where you're comfortable with. But I think that's why they keep trying cumulus because there's that different kind of inset that people can use. So who knows? But I think that's a really good point. Chris Wilson 22:18 Well, it's a great example of how your diabetes may vary. Yeah, no one solution is going to work for everyone. So that's why it's important that we have these options. Stacey Simms 22:27 Alright, so let's talk about loop. One of the other submissions. This is such a laundry list in front of the FDA is tide pool loop. And that was submitted earlier in 2021. It's been very quiet, but it is it's hanging out there. Anybody here anything? Anybody know anything? Any comments? Chris Wilson 22:45 I really haven't heard anything. I mean, it's so pure speculation. Obviously, this coming from the open source community is going to be subject to a lot probably more scrutiny than if it's coming from an established player. And I was not entirely clear on exactly what the trials for approval looked like. It sounded like some of the DIY data from DIY loot may have actually been used as part of the submission. So I would imagine that that's probably at least one of the things that may be taking a little bit extra time because I'm feeling the FDA is probably going to look a little bit more closely at that than they would if it was coming directly from Insulet. Or someone else. Stacey Simms 23:28 That's a good point and was used I believe, that's what they told me earlier this year was a lot of that open source a lot of that DIY community data was put in so you wonder what then the FDA came back and asked for no, no, what we really need is or no, that is enough. I mean, we'll find out later, but it's very interesting stuff. Kamil Armacki 23:46 And in some ways, it is a perfect storm, because it is using, you know, using that DIY technology, which is just absolutely amazing. I mean, the whole title team has been so tremendous in this project. So it's you know, taking that DIY, but then also the phone control point that we mentioned earlier, where it's an Omnipod. So actually, you know if your battery dies, I'm sure everybody's asking those questions. You know, if your iPhone dies, how is the child going to bolus? I'm sure that those are the questions that you know regulated system has to they need to have that usually answers for that. So I'm sure they face in similar scrutiny on the phone point just like Omnipod 5 does with eventually Stacey Simms 24:26 this just occurred to me and again, I don't use the system so that's probably way to think about it, but these DIY systems that already use the phone can you use your watch to control them to Kamil, I wonder if that's something that's done? Yes. Kamil Armacki 24:39 It's it's just like with Dexcom you still need your phone. So phones like the the house the home of the of the whole system, you can remotely you know, bolus and enter carbohydrates and Al's meals etc. Using your Apple Watch. Bought a phone is still required to actually do all of the calculations the brain behind all of it on Omnipod, five doc, this all happened on the pod both title loop that's all happening on the phone just like with a DIY system. Oh, yeah, that's a really good point. So you really need that to to make this system work. And there are all of those you know, your phone die in, you know, someone's stealing your phone cases that you know, I'm sure FDA is wants answers for Stacey Simms 25:22 it to be clear, because a lot a lot of information there. I think this is a good point Omnipod 5, as you said, controlled by the pod. So you lose your phone, it keeps on trucking, it's going to deliver basil, the loop will continue a tide pool loop and loop DIY, whatever it's called right now is all controlled by the phone. So if your phone dies, the system won't continue. Kamil Armacki 25:40 Well, so by design, it will always deliver background insulin in the way that it's intended. I mean, my phone dies, sometimes you know, it's live, right? I'm a 23 year old. Me because it is difficult to keep it charged in the pub. So you know it does happen. So and those are kind of a real world cases that you know, I'm sure FDA is also asking about. So with the DIY system, and I would assume with Title loop as well. But that is just my speculation. When your phone dies with the DIY system, it automatically goes to the default background rates for you kind of bolus because you need your phone to do that. And I would assume it would be relatively similar of tide pool loop, because I don't think there would be making a separate backup device like Omnipod just doing with Omnipod 5. Okay, Stacey Simms 26:31 thanks. Alright, last item that is in front of the FDA, I think is the Medtronic 780, which is already available in Europe. Right back to our conversation, but first Diabetes Connections is brought to you by Dexcom. And if you're a veteran, the Dexcom G6 continuous glucose monitoring system is now available at Veterans Affairs pharmacies in the United States. qualified veterans with type one and type two diabetes may be covered and pick it up your Dexcom supplies at the VA pharmacy may save you a lot of time to connect with your doctor for more information. Dexcom even has a discussion guide you can bring with you I know it can be hard to know what questions to ask, get that guide, find out more about eligibility at dexcom.com/veterans. Now back to Kamil answering my question about whether the Medtronic 780 is available in Europe? Kamil Armacki 27:34 That's right. Okay. So 780 G has been here for it's been approved last summer. So kind of just as COVID was kind of a couple of months in, and it's been rolled out across various countries in Europe. I think we got it in the UK earlier this year. Well, I think the 770 G's, the newest version that you guys have in the US. So the 700 pumps, they all have Bluetooth built in. So you can have your pump alarms, all of that on your phone, no control. But you can view everything by the 780s, kind of the newest pump in that line, which has a new brain new algorithm. In my view, it is completely different. Because actually, it's not really made by Medtronic. It's made by an Israeli company called Dream met. Stacey Simms 28:23 So that's free. That's right. The algorithm is from Dream Med, I've interviewed them, I forgot to actually Kamil Armacki 28:28 said that in one of my videos, and Medtronic wasn't really happy with me. So Stacey Simms 28:32 I feel like we have it's ours. Now. It's been, Kamil Armacki 28:35 they officially said something like it's built by a dream met with Medtronic engineers. So you know, it is a partnership. And that's apparently true. You know, I have no reason to deny that. So I'm sure they work together on it. But you know, the the foundation of seven ATG is actually completely different. It's not like they took 670 and added a couple of capabilities. You know, it's a great we design I mean, on the outside, it looks the same, but actually the the actual brain inside is completely different. And I guess one of the one of the key things that we mentioned is actually the ability to have your glucose set as low as 100. You know, people have diabetes across Europe, they've they've been really kind of enjoying that. And it has automatic corrections as well. So a lot of people listening to this might not be as techie as we are. So just in simple terms, it kind of matches control IQ, I would kind of say in terms of the feature set, maybe slightly better, because you can reduce your target to 100, which I know a lot of people have been asking about. I don't know if you agree, Chris, without saying it's kind of at the same level as control like you Chris Wilson 29:37 from a tech perspective. Yeah, they both the the key difference or the key feature there is the automated correction boluses, which is what differentiates what they call an advanced hybrid closed loop from just a standard hybrid closed loop, which is what the 670 and 770 were, it's nice to see more high tech options coming to the market from more players. says it gives people more options. Stacey Simms 30:01 That's interesting, though about any kind of criticism for mentioning dream, Ed, because I mean, control IQ was developed by type zero technology, right? Wasn't it like a University of Virginia thing that then Tandem bought? Yeah, well, Chris Wilson 30:14 it got bought by Dexcom Dexcom, bought type zero and then license the tech to Tandem. So Stacey Simms 30:22 interesting times. And we should also mention that all the Medtronic systems use their sensors. This is not yet a mix and match world, I believe the Medtronic sensors, and I keep hearing that they're much better, but still need to be calibrated. So even the latest version No, your shake your head, Kamil tell Oh, that's right. We're waiting for that approval in the US. Kamil Armacki 30:42 Well, so. So guardian for has been approved in three guardians. And so that's the no calibration version. And it's I know, like one person who's using it. So it's not I think they slowly roll in and out. They haven't really started shipping it yet. But it's basically what we all know, as guardian free just with with no calibrations. As far as I'm understanding the accuracy is not improved. It's kind of the same, if not slightly worse, from a margin perspective with Guardian four, compared to Guardian three. And yeah, I think it's in the FDA backlog as well. I'm gonna go ahead and Stacey Simms 31:21 just double check that on my end only because it'll be good to know the actual mark from their studies and things like that. So we'll pop that into the show notes. But I think you're exactly right, because I was just doing the time. It'll be interesting to see what the time shift is, in terms of episodes being released, because we were just doing our game show. Wait, wait, don't poke me for friends for life. And I actually I can't believe I forgot I asked this question about Guardian four. Because the codename for it or at least the in house name for it was Zeus. So we had been talking about Zeus for Medtronic for a long time, no calibrations I know this is the I get in the weeds of the trivia and then I forget what I know. So thanks for correcting me. Alright, and then Alright, let's talk about Dexcom. Because Dexcom g7, as we're taping g7 has not been submitted to the US FDA, but it has been submitted for European approval. Kamil, you had Dexcom CEO on your show, wearing and showing off the device. I was so jealous when I saw that I'm gonna yell at Kevin Sayer. Next time I talked to him. But yeah, tell us what that was like and what you thought of it when you saw it. Kamil Armacki 32:27 You know, I've been the massive Dexcom advocate, I pay for my own decks because I'm not an ambassador, I just genuinely it's been a life changing product for me. And yeah, it's been it's been an honor speaking to him. So you've spoken to him a couple of weeks after they announced that they submitted for the for the European European approval. I mean, it looks tiny, as I'm sure you've seen, if you've seen the video, I'm incredibly excited to see kind of how that one develops, and from literally a couple of days. So they kind of in the investors call, like Chris was saying, I also sometimes tune into those, and they confirmed that the expecting to get that approved in Europe by the end of the year. Stacey Simms 33:07 It's interesting. And Chris, maybe you could speak to this, for people who might not be that familiar, the Dexcom technology, while it is very different from the G6, the speed at which it might get approval, Europe is one thing, right us is another this is not like an insulin pump, we don't expect it at least to take quite as long as insulin pumps are different systems because it's not putting insulin into your body, right? It's just measuring, Chris Wilson 33:28 but it is being used to calculate doses of a high risk medication, which is insulin, there's definitely still some concern as far as how accurate it is. And if it's off it, how off? Is it? Is it going to cause a problem? But I'm really excited with the clinical data that they presented. I think it was at EASD Earlier this year, showing that the g7 the marred the that measure of accuracy that they use is actually now under 8%. With the g7 which I mean we're getting into how much more accurate can we reasonably get just because there's so much variation in human body that I mean, you can take six fingerprints from six different fingers and get six different answers from his standard meter. The fact that we're really dialing in the accuracy is as tight as we can and actually ever since is almost in the same boat with their new Wow, what any product they had. I think two versions I recall, but that's coming as well. And the the 180 day version as long as we're talking CGM. Yeah, there is no absolute answer for anything. This is actually I was in a study last Thursday, where they were seeing how long I could go without insulin. But as part of it, they're they're monitoring it with a y si, which is this reference grade laboratory meter that they actually do a blood draw and they centrifuge it down. And then they measured the glucose level in the plasma without any of the blood cells in it. And that device in the lab was actually not putting out the correct numbers, there was some sort of hiccup, they had to restart it to get it to come up. But my Dexcom was matching, and then they compared it to multiple Ultra accurate fingerstick meters and set to figure out what was going on. But, you know, nothing's perfect. This was, you know, elaborate reference glucometer. That's the most accurate one that you can get. And they don't even make them anymore. Stacey Simms 35:23 I will never forget, when Betty was little like poking the same finger, you said six different fingers, who put the same finger three times in a row because it was confusing or something. And it was always three different numbers. It's crazy. Chris Wilson 35:33 I just think it's important that people keep in mind that you know, nothing is ever going to be perfect. whatever device you're wearing, however, you're measuring your stuff, there's always going to be variation, it's never going to be exactly the same number every time on every device Stacey Simms 35:46 you mentioned ever since that's the CGM that goes under your skin. And then the transmitter goes on top. And Kamil, you are you've got a little bit are you using the libre as well like to test it out? Or did you? What did you show us earlier, Kamil Armacki 36:00 I am trying the free celebrate free, which is like the newest version. It's not available in the UK, I should make it very clear. But someone bought it for me in Germany. And they imported it over to the UK is actually it's actually been a very interesting over here. Because obviously it's it's not available in the UK. So I had to enter freestyling briefly, there was no physical receipt, but you need to get an app. So only use your phone, you can only use your phone, there's no physical reader, there's no physical device, which I don't know how that's going to work with, you know, children going to school and you know, having to carry phones, but anyway, but it's not available in the British App Store. So I had to create a German Apple ID. And everything on my phone is German. So I gem Apple Music, German podcasts, everything is in German, it's still English. But other than that I have been enjoying my German lifestyle over the last I've had it for four days now. So it's been it's been fun. Stacey Simms 37:03 What are the different features like what's I'm not as familiar with the Libre system. So what is new with the three, Kamil Armacki 37:08 it's much smaller, it's much smaller compared to the first two. And on a high level, it works exactly like you would expect a CGM to work like Dexcom web, no scan and it just always shows the value and the glucose your trends alarms ever found on your phone. So they kind of made it work in exactly the same way as at the center of Dexcom. But most importantly for me, they keep them the same price. And I think that's very important for a lot of people have diabetes here in Europe because I mean, Libra has been a giant success in the UK for example, just because actually, because of its price point it is accessible to the National Health Service. So it is you know reimbursed to you know, vast majority pretty much every single person of type one who wants it to get can get it. And libre two is the same price point is libre one and now libre free. In Germany, when they did launch, it's also the same price. So they keeping it the same, which is which is very reassuring Stacey Simms 38:08 process, we'll see what happens in the US. But that is very reassuring for our friends in Europe. I went device I meant to ask about and didn't but I don't think it's been submitted. And that is beta bionics and the iLet. And Chris, you kind of alluded to this much earlier in our talk, because you were I believe in one of those trials, Chris Wilson 38:25 I was at least told that I was patient number one at the trial site that I was at. Stacey Simms 38:33 But we don't think we don't know for sure they have not submitted down or have they? Chris Wilson 38:38 Well, I keep hearing parents and other patients still people diabetes, still saying, you know, I just finished my time in the primary phase of the trial for the eyelids, or now my kid is going into the extension phase, things like that. So if the trial is ongoing, clearly, I don't think they've they've submitted yet. It's definitely more hands off. I won't lie my time and range did go down a little bit when I was on it. Stacey Simms 39:03 But your your time and range we should specify is extremely high. Chris Wilson 39:06 Right? My 90 day average right now is 94% a week going into the current trial, the arm of the trial that I just finished was actually 97. Stacey Simms 39:20 So it's all relative, but otherwise. Yeah. But it's a good point in that, you know, the eyelid is much more hands off, as you mentioned, Chris Wilson 39:32 right? It's you know, no correction boluses there's not even mechanism to do it. All you can really do is tell it when you're eating and give it a rough guesstimate as to the meal size. So I would imagine especially for people who want to be more hands off with their diabetes and have good control because of the control wasn't bad by any stretch of the imagination, that it'll be a very good option for a lot of people once it does get approved. And this is the Insulet only version. We've still got The version with insulin and glucagon having both a gas and a brake will definitely make it easier to drive the car going forward in the next version. So we're looking forward to, to them starting the trials on that as well. Stacey Simms 40:13 Yeah, it is all relative. I mean, I just think about my son, you know, he misses a couple of meal boluses a week for sure. And I think he would happily trade off control, you know, to just have that kind of stuff be taken care of. It's so interesting to see how I mean, I'm, I'm, I know, we're gonna get somebody questions as Chris gets so much time and range, what is he doing with control IQ? So that'll be another episode tips and tricks from Chris to or maybe the maybe the tips and tricks, Kamil is just spent a lot of your time in diabetes trials? Yeah. I mean, I kidding. I know. That's not it. But Kamil Armacki 40:48 well, you're my time and ranges, but it's knowing me about? Very, very happy with it. I like to say that my time and happiness, though is 98. If not 100%? Kamil Armacki 41:00 Go? And that's what matters. Yeah, right. Stacey Simms 41:04 Absolutely. Chris Wilson 41:05 I mean, that we joke about doable, do a lot of trials. And it helps. But there is definitely some truth to that. I mean, I get to talk to and interact with some of the top endocrinologist in the world, right? Sometimes, you know, on a weekly basis. So I'm going into the clinic to have an injection of something that they're testing out or to check in and let them download the data from the device that I'm testing in half the time we're chatting while they're doing other stuff. And you know, discussing the theories that underlie a lot of this stuff. And it definitely deepens your understanding, if you want to really understand diabetes, more and more like an endocrinologist does that say, it's a great way to gain some experience? Stacey Simms 41:49 Let's talk a little bit. We've talked about what's happening and what we're waiting for. So let's talk a little bit about what we're excited for. And not just the products that we mentioned. But if there's anything else that's on your mind, I'm curious what you guys who live with diabetes, you use these devices, you follow this tech? Chris, what are you looking forward to? And I mean, it could be something that we talked about, or something that's like maybe 10 years from now, Chris Wilson 42:10 I think probably the thing that that's most interesting, I mean, to a certain extent, the tech we even if it's not there yet, we know where it's going. Yeah, where it's sort of the end point is the point is you were a sensor, you were a pump, and it does everything for you, and you don't need to worry about it. But beyond that, I think one of the things that I'm most excited about is seeing the medications that were originally designed for type twos being used in more type ones. Yeah, since most type ones do have some insulin resistance, it's actually you know, a known thing that happens, it's partly just due to the fact that normally, insulin gets made on in the middle and spreads out to the edges, and we're infusing it from the edges and having it go into the middle of the circulation. But things like I know, Stacy, you've mentioned in the past the SDLT, two drugs that help us her pee out the excess sugar from your blood, those have shown really great improvements in kidney health, cardiovascular outcomes, and making those safer for type ones, since it can cause an issue with going into DKA even though your blood sugar's stay relatively normal. That was actually the the test that I was last Thursday was checking a new drug that as an add on to help reduce the chance of that happening if you're a type one on one of these medications, but there's lots of different classes of medications that are coming out things that not only enhance the function of insulin, but potentially block some of the functions of glucagon to help improve things since they've documented that. A lot of type ones the the sort of regulation and counter regulation in insulin, the insulin glucagon axis, I guess, it does happen with a fair amount of frequency in people with type one. So that may be something moving forward. And actually, it's not even necessarily just diabetes. They're testing this medication that they were trying to lay on me as an enhancement for cancer immunotherapy. Wow. In North Carolina, I somebody was asking me about something. And so I went on the clinical trials website, it was digging into what said he's looking at this drug and found a study that they were looking at it to see if it'll enhance the ability of some immunotherapies for breast cancer. So I mean, a lot of this stuff may even have ripple effects outside of diabetes. Stacey Simms 44:33 That's really amazing. All right. That's a great point. I love that. All right. You know, you don't have to go outside of technology. I mean, that is still technology gets medication, but can we what are you looking forward to? Are you looking at down the line? I'm Kamil Armacki 44:46 going to keep this one very, very simple. I'm just looking forward to seeing more access to all of this. I feel like in terms of getting incredible technology. I feel like we could summarize all of this all of today's talking Massive tech, right? We have incredible continuous glucose monitors even better on the market. And even better versions of them are common over the next year or so with g7, libre free etc. Same with pumps, that technology so sadly, isn't really accessible to so many people. And this applies to so many regions, so many countries in the UK, we now have an a trial of 1000 people with diabetes trial in closed loop technology to hopefully have our national proof that it does work is self restraint and actually seeing all of this because, you know, it's like every single country wants their own proof even though you know, there are so many trials from all over the world proven that yes, actually, it does help people. But you know, it is a very bureaucratic process. So I'm just looking forward to actually see in 1000s, if not millions of people have access to CGM. And then if they choose to hypertrophic therapy. Stacey Simms 45:55 That's wonderful. All right. Before I let you go, this last question, it's not really a great follow up to our discussion about access. But this is one that it just honestly, it drives me bananas, and I want to get your opinion on and that is this every other day, I feel like someone is asking me when the Apple Watch is going to monitor blood glucose with non invasively. Right, that I know, right? You're gonna get the watch, it's gonna read your blood glucose and then move on. And I get these questions all the time by people outside the diabetes community, frankly, who read about it or hear about it. What's your take? I mean, I know what's coming. I hope it's coming. I don't want to I feel like I'm the hope killer. I go on these threads. And I'm like, unless you see a clinical trial, right. It's not going to happen. But I feel like it is coming it will be useful to some people sometime, right? Chris Wilson 46:44 I think, absolutely. I think there's a couple of companies that are pretty far along. In the process of actually doing non invasive glucose monitoring. I think you had an episode recently, where you mentioned one where they look at the eye, yeah, within the eye, which is cool. I've heard of a couple of different texts that are technologies that are being introduced, using either heat at low levels infrared, to potentially sense it, or radio signals, believe there's a company in Israel that's working on that as well. Yeah, they're probably not good enough to necessarily dose insulin from yet, but they're getting there and the tech keeps getting smaller and more portable and stuff, I think there's a company in Germany that's got the tabletop scale right now, where you can just basically put a finger into on the sensor and it will give you an estimate of your blood sugar in there hoping to scale that down to being a portable device that will be non invasive, and then eventually a wearable device that will be non invasive. So it's, it's definitely coming, but the stuff takes time, there's so figuring out serve a lot of the ways that the various sensing technologies interact with the body and figuring out exactly how best to estimate your blood sugar from the readings that they get back. So it's coming. I've seen presentations with actually impressive accuracy, especially considering that it's non invasive, but I don't see it any time at least probably not in the next couple of years, but especially integrated into a consumer device like an Apple Watch. Kamil Armacki 48:13 I completely agree with Chris I think especially as someone living with diabetes we tend to look at this from a you know, kind of a medical point of view but if this ever were to happen, it's really a health companion and I think that entire trend have actually seen a lot of what I would consider mainstream technology companies you know, Apple Samsung, you know, those kinds of players becoming more involved in health is a good thing because I think you know, we've heard of so many stories of you know, people using you know, Apple watches and you know being alerted that actually your heart rate is too low or too high and actually you know, if you deploy that kind of capability on you know, a population scale you know, with with millions of people using Apple Watches, it really drives you know, big changes and cold drives colossal impact on you know, general population you know, how we live our lives for if ever does happen I mean, we hear about this all the time and literally this year I think it was six or seven days after Apple Watch Series seven came out there was already a rumor saying the Apple Watch Series eight Yes. Well habit and I saw on Twitter and I just went I just did this emoji six days, six days the longest amount of time we can have without any rumors about Apple Watch. Stacey Simms 49:39 It just shows you how much money is in it Kamil Armacki 49:43 It's click bait, interesting topic because you know it is the next frontier that you know everyone is trying to tackle. Yeah, so I understand the excitement bore and sometimes I'm probably causing it because I have talked about as well. In my in my printer diabetic days, I I was excited about it. I've been excited about as Nerdabetic, and we can't not be excited. Stacey Simms 50:05 Well, even this episode, someone could clip out what Chris said it's coming. Kamil Armacki 50:09 Yeah. But we do need to be realistic about it that even when it comes in, you know, 1015 years, it probably won't really have any tangible impact on any buyer lives. Chris Wilson 50:21 Maintaining being realistic, that's a very good point. Because it reminds me of the vertex announcement a couple of weeks ago, with the the first patient of their trial, got infusion of stem cell derived Ilet cells, and is, you know, 90% reduction in insulin use. And everybody went nuts over that. And I wound up posting a big, long thread on Twitter explaining that really like this isn't the hard part yet. It's great that they're this far, it's awesome that people are pursuing different avenues, I hope they succeed. But this isn't going to be something that people are going to have in the next couple of years to just go in and get your eyelid infusion. And then you don't need to worry about measuring your blood glucose or worrying your pump or taking injections anymore. Stacey Simms 51:10 I heard a great point on that, which was if they've sent a press release, it's quite different than if they've submitted a for publication in a clinical journal. It was a little bit, I'll say a little meaner than that. I think the quote was something like, you know, if it's a press release, they're looking for money, if it's a journal they're looking for, you know, approval. There's some truth to that, though. And I think that that's a good thing for us to keep in mind as we stay very hopeful is a very hopeful crowd. And as we stay realistic, as well, I think we've run the gamut. There's always so much more to talk about. So I hope you'll come back on when these things maybe we hear more, they start to get approved, or we just talk about different things. But this was great. Thank you both so much for jumping on. Chris Wilson 51:50 It's always fun to talk to you, Stacey. Stacey Simms 51:51 Oh, thank you, thank you. It's always great to get caught up on this stuff and kind of speculate and talk about it. So thanks so much. I appreciate you guys both being here. And we will put lots of links in the show notes and everywhere else we can find them so that people can find you on social and follow your musings and your thoughts, but I really appreciate it. We'll talk to you soon. You're listening to Diabetes Connections with Stacey Simms. Lots of information there. I'm going to link up a couple of articles some things we referenced at diabetes connections.com. At the homepage for this episode, there is a transcription as well as always, what do you think? I mean, I know it was long, and there were a lot of things to get through. But I'd like to do that on a more regular basis, maybe with some different people in the community. Love to hear feedback from you what questions you have, what topics you'd like us to tackle. But man, those guys, really they know the ins and outs of all of this, they really keep their finger on the pulse. So we'll follow up. We'll do more on that. This was taped, as I said the very first week of November 2021. So in a couple of days between now and when the episode comes out, maybe something else was approved. If it happened, we will follow up on it here. All right, thank you, as always to my editor John Bukenas from audio editing solutions. We've got in the News Live every Wednesday now 4:30pm Eastern Time, on YouTube and on Facebook Live on both channels, and then we turn it around into an audio podcast episode that airs Fridays. So I hope to see you back here for that until then be kind to yourself. Diabetes Connections is a production of Stacey Simms media. All rights reserved. All wrongs avenged
Todrick Hall visits Google to discuss his fourth studio album and most personal work to date, Femuline. Femuline finds Todrick sharing the spotlight with some of music's biggest names, including Nicole Scherzinger, Tyra Banks, longtime LGBTQ+ ally Chaka Khan, and R&B legend Brandy. Todrick Hall's resume reads like a Wikipedia entry for “Major Pop Culture Events Of The 21st Century.” He's worked with everyone from Taylor Swift to Beyoncé to Pentatonix, going from national fame on American Idol to international fame via RuPaul's Drag Race, to even greater global fame through a cavalcade of viral videos that pushed him to over half a billion YouTube channel views. That's before you factor in his Broadway runs in Kinky Boots, Chicago and Waitress, or his role as dance captain on the BBC's Greatest Dancer, or the millions of streams across multiple visual albums and EPs, or his own MTV show, or his sixty-date solo tour spanning the US, Europe, Asia, New Zealand and Australia, or… Well, you get the idea. There are double threats, and there are triple threats, and then there's Todrick Hall: rapper, singer, songwriter, actor, dancer, director and choreographer. Moderated by Ricardo Horna. Visit g.co/talksatgoogle/femuline to watch the video of this event.
GrassTalkRadio.com - Episode 198 A Major Award & The Ed Davis Method In this episode I discuss an award my son received for his music composition "Run Away" and how we can learn from that. You can download his award winning composition for free right here in my online store. (In the episode I mistakenly said that his song was on his EP "Beacon". Wrong. It is on "Hands Up". But, it doesn't matter. You can download both EPs for free. I also talk about a recent gig and something you should check for if your microphones are getting long in the tooth. Then I get to the meat of the episode and explain to you the Ed Davis method of taking music lessons and how it might be something wise for you to try. I also made quick mention of one of my personally favorite creations for banjo players--The Flint Hill Scrolls eBook. You can get a copy for yourself right here. http://www.bradleylaird.com/dojo/buy-FHS.html And don't forget: Christmas Times a Coming! All you mandolin players need Jackson's eBook Christmas Songs For Mandolin. You still have plenty of time to learn them before the mistletoe is hanging. Granny don't wanna hear no Salt Creek! She wants Jingle Bells! Enjoy the show. ------------------------------------- If you like my podcast I hope you will keep this show going and growing by joining "the club" over on my Patreon page. Thank you, patrons! You can also support what I am doing by visiting my online store at http://www.payhip.com/bradleylaird. I love you all! My full website is located at http://www.bradleylaird.com. There you will find free lessons, free videos, jam tracks, full descriptions of all of my books, video lessons and courses... plenty to keep you busy.
Eps. 66: Today on Two Mics Up damednydc and our newest member to the team - guest co-host Melissa Mallory of CEO/Founder of BeUnlmtd head to Kutztown PA and sit down with City Cuts owner Jonathan Escueta and shop Manager Jerry Jones. They believe that looking your best starts with feeling your best. And that goes deeper than a haircut. It's about giving back. Doing the right thing. Creating a community. Caring about each other. And, yeah, a great haircut doesn't hurt either. Through their Books for Kids program, Jonathan and Jerry are on a mission to help kids build confidence and become great public speakers—one haircut at a time. Featuring: Jerry Escueta Owner, Jerry Jones Manager City Cuts Barbershop Kutztown PA. --- Support this podcast: https://anchor.fm/twomicsup/support
This week, we give our impressions of Mario Party Superstars & the trailers for Morbius & the Book of Boba Fett. We also list our least favorite Mario Party minigames of all time. A new Boondock Saints film is in development, Dexter: New Blood is about to begin & AGDQ 2022's game list has been released. After a 15 minute gameplay blowout, is Elden Ring a game we'll be picking up? Greg also gives his impressions of one of the more disappointing EPs of the year. Sam brings us home with another CGC TCG Spotlight. Picks of the Week/trivia - 3:47 Movies - 12:28 TV - 32:07 Gaming - 43:00 Music & CGC TCG Spotlight - 1:11:56 SUPPORT US ON PATREON: www.Patreon.com/WePodSquad FOLLOW US ON INSTAGRAM: www.Instagram.com/Wepodcastandweknowthings LIKE US ON FACEBOOK: www.Facebook.com/WePodcastAndWeKnowThings OUTRO MUSIC PROVIDED BY: Jake Fine FOLLOW JAKE & HIS AMAZING MUSIC ON INSTAGRAM: https://www.instagram.com/jfinemusic/ LIKE JAKE ON FACEBOOK: https://www.facebook.com/JakeFineMusic/
主持人：詩瑋 來賓：陳唯泰 分析師 主題:美股創高 台股虎頭蛇尾為哪樁？ 前三季財報大躍進！股價卻落難 不是不漲才剛要漲！ 本集播出日期：2021.11.04 內容： 股市熱炒店 飆股在裡面！ 聯準會宣布本月中啟動縮減購債，不急於升息，美股利空出盡三大指數再創高，台股一度收復半年線；但盤中指數由紅翻黑，亞股獨獨台股寂寞，到底為哪樁？還有有些公司體質超好，前三季EPS賺贏去年整年，股價卻落難，不是不漲是才要漲！今天陳唯泰分析師來告訴你，千萬不能錯過！ ▼更多內容▼ 股市熱炒店YT：https://pse.is/39bfcs 股市熱炒店FB：https://lihi1.cc/ceSND 股市熱炒店TG：https://pse.is/38825q 有任何問題歡迎提問! 摩爾投顧：www.morerich.com.tw/ (109)金管投顧新字第030號 本資料僅供參考，投資時應審慎評估， 興櫃股票登錄條件較上市(櫃)股票寬鬆，且無每日漲跌幅限制，投資人應審慎評估是否適合投資 ----- ▍九八新聞台@大台北地區 FM98.1 ▍官網：http://www.news98.com.tw ▍粉絲團：https://www.facebook.com/News98 ▍線上收聽：https://pse.is/R5W29 ▍APP下載 • APP Store：https://news98.page.link/apps • Google Play：https://news98.page.link/play ▍YouTube頻道：https://www.youtube.com/user/News98radio ▍Podcast • Apple Podcast：https://goo.gl/Y8dd5F • SoundCloud：https://soundcloud.com/news98
Original Release on October 11th, 2021: As the weather chills and we head towards the end of the mid-cycle transition, the S&P 500 continues to avoid a correction. How long until equities markets cool off?----- Transcript -----In case you missed it, today we are bringing you a special encore release of a recent episode. We'll be back tomorrow with a brand new episode. Welcome to Thoughts on the Market. I'm Mike Wilson, Chief Investment Officer and Chief U.S. Equity Strategist for Morgan Stanley. Along with my colleagues bringing you a variety of perspectives, I'll be talking about the latest trends in the financial marketplace. It's Monday, October 11th at 11:30 a.m. in New York. So, let's get after it. With the turning of the calendar from summer to fall, we are treated with the best weather of the year - cool nights, warm days and clear skies. In contrast, the S&P 500 has become much more volatile and choppy than the steady pattern it enjoyed for most of the year. This makes sense as it's just catching up to the rotations and rolling corrections that have been going on under the surface. While the average stock has already experienced a 10-20% correction this year, the S&P 500 has avoided it, at least so far. In our view, the S&P 500's more erratic behavior since the beginning of September coincided with the Fed's more aggressive pivot towards tapering of asset purchases. It also fits neatly with our mid-cycle transition narrative. In short, our Fire and Ice thesis is playing out. Rates are moving higher, both real and nominal, and that is weighing disproportionately on the Nasdaq and consequently the S&P 500, which is heavily weighted to these longer duration stocks. This is how the mid-cycle transition typically ends - multiples compressed for the quality stocks that lead during most of the transition. Once that de-rating is finished, we can move forward again in the bull market with improving breadth. With the Fire outcome clearly playing out over the last month due to a more hawkish Fed and higher rates, the downside risk from here will depend on how much earnings growth cools off. Decelerating growth is normal during the mid-cycle transition. However, this time the deceleration in growth may be greater than normal, especially for earnings. First, the amplitude of this cycle has been much larger than average. The recession was the fastest and steepest on record. Meanwhile, the V-shaped recovery that followed was also a record in terms of speed and acceleration. Finally, as we argued last year, operating leverage would surprise on the upside in this recovery due to the unprecedented government support that acted like a direct subsidy to corporations. Fast forward to today, and there is little doubt companies over earned in the first half of 2021. Furthermore, our analysis suggests those record earnings and margins have been extrapolated into forecasts, which is now a risk for stocks. The good news is that many stocks have already performed poorly over the past six months as the market recognized this risk. Valuations have come down in many cases, even though we see further valuation risk at the index level. The bad news is that earnings revisions and growth may actually decline for many companies. The primary culprits for these declines are threefold: payback in demand, rising costs, supply chain issues and taxes. At the end of the day, forward earnings estimates will only outright decline if management teams reduce guidance, and most will resist it until they are forced to do it. We suspect many will blame costs and even sales shortfalls on supply constraints rather than demand, thereby giving investors an excuse to look through it. As for taxes, we continue to think what ultimately passes will amount to an approximate 5% hit to 2022 S&P 500 EPS forecasts. However, the delay in the infrastructure bill to later this year has likely delayed these adjustments to earnings. The bottom line is that we are getting more confident earnings estimates will need to come down over the next several months, but we are uncertain about the timing. It could very well be right now as the third quarter earnings season brings enough margin pressure and supply chain disruption that companies decide to lower the bar. Conversely, it may take another few months to play out. Either way, we think the risk/reward still skews negatively over the next three months, even though the exact timing of cooler weather is unclear. Bottom line, one should stay more defensive in equity positioning until the winter arrives. Thanks for listening! If you enjoy the show, please leave us a review on Apple Podcasts and share Thoughts on the Market with a friend or colleague today.
Eps. 65: Today damednydc heads to North Carolina and sits down with Cheri Brice, Owner/Founder of Cheri Amour Cosmetics. Cheri is a licensed esthetician and makeup artist, and as someone that has always struggled with her skin, Cheri wanted to create a brand that catered to all skin types and was actually good for your skin. If you are looking for all natural products and the perfect holiday gift for your loved one tune in to this episode and support small black businesses. Fellas, she also has bomb skin products and oils for you beard game so check it out! Featuring: Cheri Brice - Owner/Founder Cheri Amour Cosmetics https://www.cheriamourcosmetics.com/ --- Support this podcast: https://anchor.fm/twomicsup/support
Radio Thrift Shop - homemade and homegrown radio from DJ who doesn't know the rules and can barely announce anyway. - Dig into DJ Frederick's musical themes (i.e. Forgotten 45's, private press LPS, library music and listen to seldom heard LPs, EPs, 45's, scratchy 78's, cassettes & cds - classic rock and pop, jazz, exotica, folk, acoustic, folk-rock, indie pop, lo-fi, psychedelic, jam bands, library, easy listening & just about everything else I dig out of the crates. Hopefully it all makes sense by the end of the hour. Occasionally these shows include documentaries or segments about the history and culture of music and/or radio. I invite your LPFM, Part 15, online or other radio project to include Radio Thrift Shop in your schedule. I've been on the air for 22 years at WSCS which is the "home base" for this show. WSCS broadcasts RTS Saturday evenings @10 pm eastern time in New London NH at 90.9 and online at classicalwscs.org. DJ Frederick wishes to express gratitude to all Radio Thrift Shop listeners and community / non-commercial radio supporters everywhere. Thank you for downloading this homemade homemade DIY show. WMNB-LP 107.1 in North Adams MA airs Radio Thrift Shop on Mondays at 6:00pm eastern time. Radio Thrift shop is now broadcast in New Orleans via WXDR-LP 99.1. Thursdays at 9 pm Eastern time. http://dolphinradio.org/ Radio Thrift Shop is heard on 92.7 WLSL-LP Saint Leo University Radio Sundays at Noon ET. Chiampa Radio broadcasts RTS Monday through Friday at 12:30 pm est - chiampa.org Listen to WLSL-LP online at: http://player.live365.com/a27373?l PLEASE LET ME KNOW IF YOU ARE BROADCASTING THIS SHOW WHERE & WHEN SO THAT I CAN PROMOTE TO RADIO THRIFT SHOP LISTENERS. Musical requests or ideas for themes for future programs are welcomed at freeradioskybird@icloud.com Credits: Radio Thrift Shop is a homemade, homespun show created and produced by DJ Frederick (who clearly has a face for radio) and recorded on obsolete equipment. RTS has been broadcast continuously since 1999 on WSCS 90.9 in New London NH currently airing on Saturday evenings from 10 pm until midnight eastern time. DJ Frederick has been at WSCS for 22+ years & 46 years on the airwaves since walking into the studios at WUNH 91.3 in Durham NH. Notes: Radio Thrift Shop is DJ Frederick's two decade long (and counting) radio experiment. Radio Thrift Shop enjoys a freeform format & is an homage to the non-commercial era of broadcasts of the 1960's and 1970's that DJ Frederick grew up listening to. RTS features a mix of vinyl records, 78s, 45's, LPs, private press releases, and a variety of cassette tapes and homemade / self released cassettes & cds. Each broadcast features an improvised or thematic playlist from DJ Frederick's music shelf Credits: Radio Thrift Shop is a homemade, homespun show created and produced by DJ Frederick (who clearly has a face for radio) and recorded on obsolete equipment. RTS has been broadcast continuously since 1999 on WSCS 90.9 in New London NH currently airing on Saturday evenings from 10 pm until midnight eastern time. DJ Frederick has been at WSCS for 22+ years & 46 years on the airwaves since walking into the studios at WUNH 91.3 in Durham NH Notes: Radio Thrift Shop is DJ Frederick's two decade long (and counting) radio experiment. Radio Thrift Shop enjoys a freeform format & is an homage to the non-commercial era of broadcasts of the 1960's and 1970's that DJ Frederick grew up listening to. Each broadcast features a mix of vinyl records, 78s, 45's, LPs, private press releases, and a variety of cassette tapes and homemade / self released cassettes & cds. Each broadcast features an improvised or thematic playlist from DJ Frederick's music shelf. For anyone who is curious, RTS 541 is currently lost somewhere in the cyber void.
Don't be jealous of my MOOSE-Y! We tawkin' Canada's Drag Race Season 2 Eps 1 & 2 with Mano Agapion & Oscar Montoya! WOW! Listen to these h8ful gays talk about those werkroom entrances, those truly gaggy runways, & that fucking crazy musical! Go watch the eps on Wow Presents Plus! KIKI with us at Drag Her's IG! PREPARE TO GAG, WHORES!!!!! PROPS TO YA, DWOTUR! BUY OUR MERCH! 50% of everything we make goes to The Okra Project! If you rate Drag Her 5-stars on Apple Podcasts & leave us ANY UNPOPULAR RPDR OPINION, we'll discuss it on the pod!!!!! DO IT!! AND PLUS AND!!! Go to our IG to watch our super special IG LIVES covering Drag Race UK! Black Lives Matter. DONATE NOW! Listen to Drag Her on Stitcher, download the app, or get more info at stitcherapp.com/dragher! Get more Mano on We Love Trash & Podcast Killed The Video Star! Drag Her IG: dragherpodcast Theme Song: Twinkids (@twinkidsmusic) Art by Jack Manion (@jackmanion) Advertise on Drag Her via Gumball.fm See omnystudio.com/listener for privacy information.
I won't even lie it being hard keeping up with the songs coming out of Nigeria lately, singles, EPs, albums, songs just dey drop anyhow but then again, this is why I'm your Musical Plug, plugging you to the best of the best songs out there. That said, good day ladies and gentlemen, boys and girls and members of the Cha Cha Nation, my name is Hafeestonova and this is the Cha Cha EP Compilation Series Vol.4. This is series is where I plug you into some of the dope EP I have been listening to and in this episode, I talked about four EPs from Magixx (Magixx EP), Veeiye (Young & Reckless ), Seyi Vibez (No Seyi No Vibe {NSNV})and Ycee (Love Drunk) Click on the play button to listen Here are links to the EPs talked about 1. Magixx- Magixx EP -https://open.spotify.com/album/4FZn99wJYWhH3sczHcDJDD?si=kRsvop0ISdyFwF4gqhTdHw 2. Veeiye- Young & Reckless - https://open.spotify.com/album/2u3DOrYYFvorXEonfn99Mr?si=rvV-CYk1QB29liXLLjHYXg 3. Seyi Vibez- No Seyi No Vibe (NSNV)- https://open.spotify.com/album/3gyK6F0XDj55xbeBzzyif7?si=kKqW_W8WSxSblt2YPYX5GQ 4. Ycee- Love Drunk- https://open.spotify.com/album/5d0oU10qoxpnSpa4PCaKXo?si=C_ZbfB0PTn2eTG_UFRtKrQ Intro and Outro song: Cha Cha Anthem -https://audiomack.com/chachamusicreviewpodcast/song/cha-cha-anthem --- Send in a voice message: https://anchor.fm/hafeestonova1/message Support this podcast: https://anchor.fm/hafeestonova1/support
Born in the UK and based in Berlin, Cressida's sound is a cross-pollination of these two sonic spectrums - the rhythmic, dystopian force of Techno fused with a sound embedded in various points of the UK Hardcore Continuum Cressida marked his first release “Salvation“ EP on Nur Jaber's OSF label and tracks on compilations for both Dax J's Monnom Black and Mord in 2018. After two more EPs on Voitax he contributed a track to the Midnight Shift x Voitax collab LP in late 2020. Far from going unnoticed, his work has been heralded by luminary artists such as Dax J, Paula Temple, Rebekah, FJAAK to name a few. His performances have gathered at an even faster pace with shows in North America, Asia and across Europe, plus key appearances at institutions like Tresor, Berghain's Säule, //about:blank and Griessmuehle in his adopted hometown. He has also made key contributions to renowned mix series such as HATE & Groove Magazine as well as appearing on the mighty RinseFM, amongst many others. His next gig will be on 30th of October at Berghain. His recent releases include appearances on Hector Oaks' KAOS imprint and Natural Selection https://soundcloud.com/cressida https://www.instagram.com/cressida_____/
My guest this week is singer-songwriter Dodie. She started out by uploading original songs and covers to YouTube back in 2007, and now she's got almost 2 million YouTube subscribers, 3 EPs, and 1 full-length album. On this episode, we talk about creating a career using YouTube, the best recording session of Dodie's life, and how a music career starting from YouTube varies compared to a more traditional route. We also dive into talking about constantly growing as an artist, and how to defy expectations, even when people just want you to play your hits. You can submit your questions to Ben here: https://www.speakpipe.com/BenFolds And check out the YouTube channel here: https://www.youtube.com/channel/UC9ix6szTyjg3vmx1sIj-Vfw See omnystudio.com/listener for privacy information.
Debates in D.C. continue to make headlines, but even with lowered expectations for the Biden agenda, we find a robust set of climate-focused provisions likely to survive the process and benefit the clean tech sector. ----- Transcript -----Michael Zezas Welcome to Thoughts on the Market. I'm Michael Zezas, head of U.S. public policy research and municipal strategy for Morgan Stanley.Stephen Byrd And I'm Stephen Byrd, head of Morgan Stanley's North American Research for the Power and Utilities and Clean Energy Industries.Michael Zezas And on this edition of the podcast, we'll be talking about clean energy and the latest developments for the bipartisan infrastructure deal and President Biden's build back better agenda. It's Tuesday, October 26th at 10 a.m. in New York.Michael Zezas So Steven, with the negotiations winding down on the legislation Congress is considering around the president's economic agenda, I wanted to speak with you because you cover a sector, clean tech, that's really at the nexus of many things Congress and the White House are trying to achieve. In particular, even as the size of the economic and climate package has been cut from $6 trillion dollars to $3.5 trillion dollars now, perhaps as low as $1.5 trillion dollars, one constant has been a potentially large amount earmarked for clean energy infrastructure. By our estimate, there could be roughly $500 billion of new money allocated towards this goal. So, last month on the podcast, you outlined eight headline proposals, maybe we could start by updating everyone on those proposals as they stand now in the scaled back version of the bill.Stephen Byrd Yeah, thanks, Mike. There is still a lot of support for clean energy in the draft legislation. Let me walk through the eight elements that investors have been most focused on to give you a sense for just how broad that support is.Stephen Byrd Number one, and the boldest of these proposals is a clean electricity performance program or CEPP. This would essentially push all utilities and load serving entities to adopt clean energy and phase out fossil fuels. Number two is a new tax credit for energy storage and biofuels. Number three is a major extension of tax credits for wind, solar, fuel cells and carbon capture, and the payment for many of these technologies is higher than they've been in the past. Number four is significant incentives for domestic manufacturing of clean energy equipment. Number five is what's often referred to as direct pay for tax credits. This essentially provides owners with the immediate cash benefit of tax losses; that avoids these companies needing to go monetize those tax losses via the tax equity market to the same extent that they do now. Number six is support for nuclear power. There's a production tax credit for nuclear power output. Number seven is a major clean hydrogen tax credit. And number eight is significant capital to reduce the risk of wildfires. So it is very broad, very far reaching. It has impacts across the board.Michael Zezas So, which kinds of companies do you think stand to benefit the most from this funding?Stephen Byrd It's really interesting, quite a few subsectors that I cover would receive significant benefit here, I'll highlight the biggest beneficiary. So first, any company involved in green hydrogen, I see quite a bit of benefit here. The tax credit for green hydrogen is $3 a kilogram. That is a very large amount. And we think will incent customers to adopt green hydrogen more quickly. It will incent developers to build out the infrastructure needed to both produce and distribute green hydrogen. So, a number of companies from fuel cell companies to those involved in the industrial gas business to clean energy developers, I think will see a significant benefit there. Another category would be renewable development companies. So, the tax credit for wind and solar and storage is increased. In the case of storage, this is the first time energy storage would get a tax credit, and this further lowers the cost of clean energy. Another category that could be quite significant is carbon capture and sequestration. This technology would receive a significant benefit in terms of the payment per ton of hydrogen. And we believe in many cases, this is going to be really the amount needed to get essentially over the finish line. That is, to provide enough support for those big carbon capture projects to actually get built, which is really quite exciting. Biofuels gets a big benefit. Anyone who wants nuclear power would receive a significant benefit. And also, companies that are working to reduce the risk of wildfires would receive significant government support. So, you can tell it's just very broad and touches on really every subsector that we cover.Michael Zezas Now, the Clean Electricity Performance Program, or CEPP, will likely end up on the cutting room floor. Why is this program's exclusion not a bigger problem in your mind?Stephen Byrd The CEPP, it's really interesting. It certainly is a very bold effort to reduce fossil fuel usage. What we find here, though, is that all of the other provisions are so significant that we believe the adoption of clean energy will continue at a rapid rate. To give you a sense, in 2020 renewable energy in the United States was about 11 percent of power output. By 2030, we project that that can approach around 40 percent. That is a huge increase in just a decade. That is predominantly driven by economics. The cost of wind, solar and energy storage is dropping so quickly that many customers are adopting clean energy based purely on economic grounds, and the elements of support in this draft legislation would further enhance those economics and push customers in that direction anyway. So, we do see a big shift occurring, with or without the CEPP. Fortunately, there are many other elements of support in this draft legislation that we think is going to really provide a boost to many clean tech technologies, many business models, and we're excited about the growth that that would bring.Michael Zezas What about the other types of companies you cover, utilities? This government investment seems like a step toward developing a very different type of business model for them. What do you think the outlook for the sector is?Stephen Byrd I'd say the government support for clean energy that's in this draft legislation does have a number of benefits for utilities. So, we see in parts of the country a virtuous cycle that's been forming. And let me walk through how this is playing out. The coal power plants in many parts of the U.S. are quite expensive compared to renewable energy. So, for example, in the Midwest, the cash cost to run a coal plant could be three times as high as it costs to build a new wind farm. And so what utilities are doing is they are in a very careful, measured way shutting down coal, replacing that coal typically with a combination of wind and solar and energy storage. And typically, customer bills are not going up as a result, because of the benefit from avoiding the cost of running those coal plants. That virtuous cycle is resulting in better earnings per share growth. Now, with the government support that we're seeing in this draft legislation, that shift will accelerate. We will see more transmission spending, for example, more energy storage spending. It will boost the economics of wind and solar, which is fantastic. Also, in terms of risk mitigation, the capital that's in the bill that would help with dealing with the physical damage from climate change, such as wildfires, is another area of benefit. The cost from climate change to our sector is rising. And so government support there will help essentially defray a cost that's becoming quite significant for some of our utilities. So, you know, I think you're right to point this out. The utility sector is quite a big beneficiary here. And, you know, many of our best-in-class utilities can achieve, we think 7%, sometimes 8% EPS growth over a very long time period. By very long, I mean, a multi-decade time period. That to us is quite exciting because risk adjusted, that growth is quite excellent. For many of our utilities, the risk to achieve that is fairly low because the economics of what they're doing is so clear and so compelling. So, we are excited about the impacts to the utility sector.Michael Zezas Steven, thanks for taking the time to talk.Stephen Byrd Great talking with you, Michael.Michael Zezas As a reminder, if you enjoy Thoughts on the Market, please take a moment to review us on the Apple Podcasts app. It helps more people find the show.
Wall Street projects a “higher for longer” era for oil pricesttps://www.worldoil.com/news/2021/10/22/wall-street-projects-a-higher-for-longer-era-for-oil-prices- An era has to be long enough to change how the industry functions- Citigroup Inc. said in a report this month that crude below $30 and above $60 looks unsustainable in the long-term. - Ed Morse thinks prolonged over $50 will bring 7 million bpd on the marketNearly half of American companies say they are short on skilled workershttps://www.cnn.com/2021/10/25/economy/business-conditions-worker-shortage/index.html- will "labor shortage" (companies' inability to hire workers) create permanently elevated business costs?Solar and Wind Force Poverty on Africahttps://www.wsj.com/articles/solar-wind-force-poverty-on-africa-climate-change-uganda-11635092219- Africa can't sacrifice its future prosperity for Western climate goals- Neo-imperialism to impose a narrative that Africa can't access fossil fuels and must be consigned to solar/wind which isn't nearly as effective at providing electricity.- OPEC is sympathetic to this message. Will Africa save OPEC? Can OPEC save Africa?Tesla shares rise after Hertz says it will buy 100,000 electric vehicleshttps://www.cnbc.com/2021/10/25/tesla-shares-up-on-news-hertz-will-purchase-100000-electric-vehicles.html- Good idea for Hertz because Teslas will be a big draw for people who want to drive Teslas on vacation.Ahead of COP26, Saudi Arabia Resists Calls to Cut Oil Investmenthttps://www.wsj.com/articles/ahead-of-cop26-saudi-arabia-resists-calls-to-cut-oil-investment-11634911150Special Guest Rhett Bennett of Black Mountain Co.https://www.blackmountainoilandgas.com- Drilling situation in the US: real issues from labor situation. Labor is always a bit of an issue in Permian, but also in Eagle Ford. On the drilling side as well. Supply chain issues, also exacerbated for oil industry because of severity of downturn.- metals aren't available to implement transition in the way needed for transition- Sees oil over $100, higher natural gas prices this winter- Price increases will drive activity higher. Private companies are drilling a lot, public companies more constrained.- "If you are private, it's a beautiful scenario." Inputs on the cost side of the ledger haven't risen nearly as much as the returns side of the ledger.- Haynesville wells pay for themselves in 90 days - but they are quite dry, Permian wells are more heavily oil weighted.- 2022 budgets: lots of E&Ps will want to increase drilling activity 20-30% and will want budget increases of similar amount. But will also have inflationary pressures that will hit production targets and so many will fall short.- E&Ps did better consolidating during downturn that service companies so there's still a lot of competition in service sector- Consequences of capital starvation. Shale is a treadmill. If you hop off, looking at 50-60% decline rate.- Underground carbon sequestration (CCUS) - will it be economical without legislation on carbon tax in the US? CCUS in Australia - lots of capacity for sequestration in Australia.- Lots of countries don't have the right geology to inject and store carbon. Potential for this to become an import/export industry.- Sees battery tech as competitive with ICE engines. Problem is materials and minerals.- Metals and mining has had capital starvation for decades now. Average mine takes 7 years to go from discovery to production.
We had the pleasure of interviewing Highland Kites over Zoom video! Highland Kites started as Los Angeles native Marissa Lamar's solo project, and was a way for her to deal with the aftermath of her beating a severe case of neurologic Lyme Disease, losing much of her earlier life in the process. Music was a way to deal with not just the pain, but to help her heal and find a new purpose. Having never played or sung she started learning piano in 2014 at 26 and within 6 months played her first show. What started as just something to help her mind heal and give her an artistic outlet became an obsession and something she fell deeply in love with.She shortly after met drummer, Neil Briggs through a mutual friend. Their musical styles were very different but the contrast created a sound that they both resonated with.They have since released 4 EPs, a full length album and many singles, done 6 tours and over 100 shows. Their music has been described as “Hope Sandoval fronting Radiohead”. They have a love for adding texture to songs, and creating dreamy landscapes around brutally honest and direct lyrics.We want to hear from you! Please email Tera@BringinitBackwards.com.www.BringinitBackwards.com#podcast #interview #bringinbackpod #HighlandKites #zoomListen & Subscribe to BiBFollow our podcast on Instagram and Twitter!
Eps. 64: What you sippin' on? Today damednydc heads to Ohio and sits down with Chris Chapanar, host of the Whiskey Noobs Podcast. With the seasons change, and the nip is in the air we talk about warming up with whiskey. Chris helps give us an introduction to all things whiskey. How it's made, distilled, the various types and more. If you are looking to take a sip, tune in and enjoy the conversation! Featuring: Chris Chapanar - Host of the Whiskey Noobs Podcast --- Support this podcast: https://anchor.fm/twomicsup/support
Hooswhere podcast is where UVA alums catch up with UVA alums. Hosted by Chase Minnifield, and Max Milien they catch up with UVA alumni's and see what they are doing post graduation in business, life and entrepreneurship.EPS 156 ft. Chris Cook - former UVA football CB and former NFL CB. We discuss with Chris his experience at UVA, in the NFL and post football starting his own Training BusinessWebsite: http://www.hooswherepodcast.com/Apple Podcast: https://podcasts.apple.com/us/podcast/hooswhere-podcast/id1323846995Spotify Podcast: https://open.spotify.com/show/6f4eQqazn8BniHhkc8RfSeChase Minnifield: @chaseminnifieldMax Milien: @multimili
Since we only have special people here in the dHarmic Evolution, we got a really special young lady to join us today. Strap up your seatbelts, because we're taking a ride today from the Music City all the way to Georgia. Ladies and gentlemen, we've got Beth Crowley! Beth first gained recognition on YouTube back in 2011. She was inspired by a comedic group called Axis of Awesome and she posted a medley of popular songs titled, “Greatest Song Ever Written.” The song was quickly picked up by Reddit, BuzzFeed, and Tumblr, and now this video has over a million views on YouTube. From 2014, Beth already has released one full-length album, two EPs, and numerous singles. Her book-inspired music includes songs based on the Dark Artifices series, The Divergent series, the Lunar Chronicles, Harry Potter, the Hunger Games, The Fault in Our Stars, the Shatter Me series, and many more. She's also written several commissioned custom songs for books and book series. Coming from Nashville and now back in Georgia, Beth continues to write and release new music. She's also started writing her first young adult novel. It was a real pleasure learning about Beth Crowley, her music, and all the things that she's doing in her book. There's a lot more to see of her in the future. But for now, let's get to know more about her here on the dHarmic Evolution! More about Beth Crowley Beth Crowley wants to thank her listeners for continuing to support her dream of writing meaningful music, and if you haven't listened to her yet, check out all her links below. She is most active on Instagram as it is more interactive, but you can look at all the social media platforms provided below! Quotes: 04:20 “I think a lot of people had that moment this past year of being like, “Why am I away from things that are important to me if I don't have to be?” 13:00 “I love lyrics and I love language and I just had the imagery for this song of where storms are, like very impactful and sometimes terrible but I was fascinated by the idea that there are people that actually seek them out like they get some kind of reward out of going into the storms rather than going away from them.” 19:11 “My ideal situation is to be able to traditionally publish this book and have the soundtrack that goes with it and be able to tour and actually play. Like, have a book tour and play music at the same time. I think that would be such a cool format for touring.” 23:27 “I hope that I'm in a position someday where I would be able to have a series of shows and not have to worry about nobody showing up for them. Because I've definitely been there where I had a show that just nobody came to and that's very humbling.” 37:45 “It really is an interesting combination of being so satisfied with the music but also, all of the memories and associations that come with the experience and so I'm just really grateful that I think that's probably something that not everyone is lucky enough to have, that they not only have an album that they really believe in but they had a great experience doing it, and so just everything about it was more than I could have hoped for.” 47:54 “I would say the biggest thing is don't go for that instantaneous viral moment. Build a foundation, which takes time. If you're building a house, you build a foundation, and you do it slowly and carefully, so you can have the rest of the house be supported by that. It doesn't have to happen quickly. If you stick with it, and you work hard, it's not like a guarantee that stuff will happen for you, but it certainly increases your chances. But you have to make things happen for yourself. You can't sit back and wait for them to happen.” Timestamps: 01:06 Introducing Beth Crowley 02:32 How was Beth's move from Nashville to Georgia? 07:04 Listen to “Storm Chaser” by Beth Crowley 10:59 What is the metaphor and what is Storm Chaser about? 13:41 How was her experience filming a video of the writing process for Storm Chaser? 15:12 How was Beth's process of creating a song? 17:17 What are Beth's tricks on hanging onto the ideas and getting something 18:24 Aside from being a songwriter, Beth is also writing books and is writing her first novel. 20:12 Is Beth performing or has any plans on taking her music to Georgia? 21:54 The advantages of using online platforms to reach out to a larger audience 23:47 Beth shares about live streaming on YouTube, Facebook, and other platforms. 28:09 What is “YOU'RE EXHAUSTING” about? 29:25 Listen to “YOU'RE EXHAUSTING” by Beth Crowley 32:30 Beth shares the production of her songs and how she met her producer, 35:46 How was Beth's first album project back in 2014? 40:25 What does Beth do for downtime or chilling out? 43:26 What is Beth's main instrument? 44:10 What are Beth's goals in the future? 46:15 What is the best place for people to connect with Beth Crowley? 47:31 What does Beth want to say to the audience, especially the young upcoming musicians? 49:34 Listen to “Ride On” by James Kevin O'Connor Spotify Playlist: Check out our three dHarmic Rising Stars playlists and listen to great artists who have been a guest on the show. If you have been a guest, you can see hear music here. Send the links to your family and friends as well! dHarmic Rising Stars: Aquila https://open.spotify.com/playlist/4loDaYF0OuWRjZeMXvEjK4 dHarmic Rising Stars: Orion https://open.spotify.com/playlist/5CnL9tl0xbU4oDh6jtJBZx dHarmic Rising Stars: Lyra https://open.spotify.com/playlist/1ov0OqNMJmPhHrxZjsXthS dHarmic Evolution links: Head over to dharmicevolution.com and subscribe to your favorite platform. Let me know what you think too, by simply leaving a comment! “7 Steps to Mental Freedom” This book is accessible through the website and it is a great help for people suffering from anxiety and depression. Do you know someone? Have them go to dharmicevolution.com so they can read this. Check out the Facebook Page as well so you are up to date with everything that we are doing. Visit the link here: dHarmic Evolution Saying hello to friends who are artists, singers, songwriters, keynote speakers, or any creatives! Feel free to join our group where you can share your content and let the world know what you do and support you. Go to: dHarmic Evolution Community. Hey, if you're around New Jersey, “Dr. Scientist” from Austin Texas has shown in the area. October 29 - Tavern Off The Green in Morristown, New Jersey October 30 - Johnnies Tavern in Boonton, New Jersey At 9 PM for both evenings, I will be opening the show with my son Trevor, for this event. I hope to see you there! Special links and Mentions: Dolly Parton Tony Robbins Daniel Dennis of Prime Cut Studio Michelle Branch Music Row Connect with Beth Crowley Website: https://www.bethcrowley.com/ Instagram: https://www.instagram.com/bethjcrowley/ Facebook: https://www.facebook.com/bethcrowleymusic Twitter: https://twitter.com/bethjcrowley YouTube: https://www.youtube.com/channel/UCKiamQNDwgPEj38TvPlsTBQ YouTube Music: https://music.youtube.com/channel/UCI0yTzfuZj1DBxaqIa21Z8Q Spotify: https://open.spotify.com/artist/70Mtv8bWyfIXjxORsNnqq6 Apple Music: https://music.apple.com/us/artist/beth-crowley/491629667 Deezer: https://www.deezer.com/us/artist/5361961
On today's episode, I talk to musician and actor Katelyn Tarver. After getting her start performing in prestigious talent competitions as a child in Glennville, Georgia, Katelyn moved to Los Angeles at the age of 19 to pursue a career in the entertainment industry. She promptly made her TV debut with a recurring role on Nickelodeon's Big Time Rush, then began independently releasing her music while penning songs for other artists. In 2014 she experienced a major breakthrough when “Crazy Stupid Love” (a song she'd co-written for British pop star Cheryl) shot to #1 on the UK Singles Chart. Since then, Katelyn's released a number of singles and EPs, recurred on shows like The Secret Life of the American Teenager and Ballers, and her latest album Subject to Change will be released very soon, in early November! This is the website for Beginnings, subscribe on Apple Podcasts, follow me on Twitter.
This week's guest is Belvedere singer, guitarist and founding member Steve Rawles. Since staring in 1995, the Calgary, Alberta-based band has shared the stage with many of punk rock's biggest names, released a number of great EPs and albums, and played more than 1,500 shows in more than 40 countries. After spending more than a quarter century traveling the world with Belvedere, This Is a Standoff and as a solo performer, Rawles has quite a collection of entertaining stories and important lessons he's learned along the way. Recently, Rawles spent part of his two-day break between legs of Belvedere's ongoing Canadian tour speaking to My First Band host Tyler Maas about the band's new album (Hindsight Is the Sixth Sense), getting back on the road after the COVID-19 pandemic forced the perpetually touring outfit to stay home and plans he has for 2022 (and beyond). Of course, the interview also touched on Rawles musical start, including taking piano and trumpet lessons as a kid, beginning a label as a teenager, starting Belvedere with little-to-no expectations in college, and some of the best — and weirdest — moments from his decades on stage. Along the way, also talked about his Merit-Based Booking agency, some of his favorite places to perform and things he still hopes to do before his career as a touring musician is all said and done. My First Band is sponsored by Mystery Room Mastering and Lakefront Brewery. The show is edited by Jared Blohm. You can listen to My First Band on iTunes, Stitcher, Spotify and wherever else you get podcasts. You can also listen to rebroadcasts of previous My First Band episodes on WMSE every Wednesday from noon to 12:30 p.m. CST. Music used in this episode comes courtesy of Devils Teeth ("The Junction Street Eight Tigers") and Belvedere ("Happily Never After").
Step 1 - Wholesaling Houses - Master ARV's - Comps 101 Eps #40
Can't Find Comps to Determine ARV's for Wholesaling Houses Coms 101 Eps #37
Why Start with ARV's - Comps 101 Eps #39
We had the pleasure of interviewing Jaci Butler over Zoom video! LA-based singer, songwriter, and creator, Jaci Butler, releases the first single off her upcoming EP, “Breakup Season,” today. With an accompanying music video, this track is “about starting anew on your own; whether that's breaking up with a job, relationship; however you see fit for you as a listener.It's about the changing of time. Realizing it's time to break off with the old, find yourself, acknowledge that it's been over for a while, and it's finally time to let go” Jaci says. She elaborates; “There's all these things I believe in - whether it be fate, good luck charms, love - and they all play a part in my life. This song is also super special to me because I got to reunite with a fellow American Idol Alum, Avalon Young, who helped me co-write.”Hailing from Dallas, Jaci has been paving her own way in the entertainment world since 2009. As the lead singer and founder of Dallas-based Jagged Row, she toured all over North America collecting over 600 shows under her belt. Throughout the band's 8 year stint, they recorded 4 EPS, 1 full - length album, and opened for acts such as Hanson, Bowling for Soup, Dalton Rapattoni, etc. Jaci's solo journey officially kicked off after joiningmusical.ly in 2017 and moving to Los Angeles the following year; where she then released "Color Me You" and garnered 1 million fans on the app. A few years later, and 4.1 million + TikTok fans later; you'll find Jaci playing Roblox daily with the 700K+ Lucky Charms on her gaming Youtube Channel, and singing and vlogging on her other various platforms.Currently, in the studio recording her first self-produced EP as a solo artist, Jaci says “I was in a band for so long and released multiple projects, but this is the first time I feel like I'm putting myself out there and being 100% vulnerable with the things I've written. I'm excited for people who know me online, on TikTok or as a gamer, to see that I'm also a serious musician. I'm coming out as Jaci the musician!”We want to hear from you! Please email Tera@BringinitBackwards.com.www.BringinitBackwards.com#podcast #interview #bringinbackpod #JaciButler #zoomListen & Subscribe to BiBFollow our podcast on Instagram and Twitter!
On today's episode, I talk to musician Buzz Osborne. Originally from Morton, WA, Buzz founded the rock band Melvins in the early '80s, and in 1986, C/Z Records released their first EP Six Songs. Since then, they've released over 40 more albums, EPs and compilations on record labels like Alternative Tentacles, Sub Pop and Ipecac Recordings, and while never achieving mainstream success - if that's even something they sought - the band is both sustainable and hugely influential, influencing everyone from Nirvana and Soundgarden to Helmet, Tool, Mastodon and many others. Their latest album, Five Legged Dog, a 36-song acoustic reimagining of their discography, is out now! This is the website for Beginnings, subscribe on Apple Podcasts, follow me on Twitter.
In 1989, Mac McCaughan co-founded the band Superchunk. The band was abrasive and vulnerable; Guitars dominated their sound, with Mac's voice sitting low in the mix. The band caught on and became huge. So big, they helped coin the Gen X term "Slacker" with their 1990 hit "Slack Motherf--ker." To release Superchunk's albums, Mac and his bandmates started their own label: Merge Records. Mac is also a solo artist. He's released a handful of albums and EPs under his own name, in a broad range of genres. He's made everything from folk rock to ambient music. His latest record is called The Sound of Yourself. It's a fun pop record that caught the ear of our friend Jordan Morris. They talk about recording an album during lockdown, using samples in songwriting, and what makes a good sax solo on a pop record.
© 2020-2021 Ivy Podcast Discovery LLC
